Component
L-Citrulline
L-Citrulline is a non-proteinogenic amino acid made in the body. It participates in nitrogen disposal and supplies arginine through ASS1 and ASL. Low blood citrulline, impaired conversion and dietary intake are distinct; each mechanism retains its experimental scope.
56 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
At 3 g twice daily, the arginine/ADMA ratio rose from 186 to 278.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/17662090.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b", "start_char": 0, "end_char": 1980, "text_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b"}
- experimental_model
- Double-blind placebo-controlled crossover study
- exposure
- Citrulline 0.75, 1.5 or 3 g twice daily versus arginine formulations; one-week periods
- limitations
- Small short trial; NO-related urine markers do not establish a clinically meaningful vascular benefit.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 20 healthy volunteers
- plain_language
- The substrate-to-inhibitor ratio changed; this does not mean ADMA itself was removed.
- primary_references
- [citrulline-p17662090] Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. (2008). https://pubmed.ncbi.nlm.nih.gov/17662090/ DOI: 10.1111/j.1365-2125.2007.02990.x
- tissue_or_cell_type
- Plasma amino acids, urine NO markers and brachial FMD
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 879–890
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind placebo-controlled crossover study · source_derived_draft · unverified_draft
### citrulline-adma-ratio At 3 g twice daily, the arginine/ADMA ratio rose from 186 to 278. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The substrate-to-inhibitor ratio changed; this does not mean ADMA itself was removed. organism: Human, 20 healthy volunteers tissue_or_cell_type: Plasma amino acids, urine NO markers and brachial FMD experimental_model: Double-blind placebo-controlled crossover study limitations: Small short trial; NO-related urine markers do not establish a clinically meaningful vascular benefit. exposure: Citrulline 0.75, 1.5 or 3 g twice daily versus arginine formulations; one-week periods evidence_span: {"source_cache": "artifacts/citrulline-research/17662090.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b", "start_char": 0, "end_char": 1980, "text_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b"} [citrulline-p17662090] Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. (2008). https://pubmed.ncbi.nlm.nih.gov/17662090/ DOI: 10.1111/j.1365-2125.2007.02990.x
Complete structured claim and evidenceThe FMD/NMD ratio increased by 0.12 with citrulline versus 0.01 with placebo in the CAD trial.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/27648629.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7584e325856443da6067298d1c6ab31b95679839361f4a60adc5f7434944fb17", "start_char": 0, "end_char": 1848, "text_sha256": "7584e325856443da6067298d1c6ab31b95679839361f4a60adc5f7434944fb17"}
- experimental_model
- Randomized placebo crossover vascular trial
- exposure
- Fifteen-day L-citrulline and placebo periods
- limitations
- Small surrogate trial; abstract reports unusual FMD units, so only the dimensionless ratio is extracted.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 30 coronary-artery-disease patients
- plain_language
- A vascular-response ratio improved in this selected patient group.
- primary_references
- [citrulline-p27648629] The Assessment of short-term effect of L-Citrulline on endothelial function via FMD to NMD ratio in known CAD patients: A randomized, cross-over clinical trial (Clinical trial number: NCT02638727). (2017). https://pubmed.ncbi.nlm.nih.gov/27648629/ DOI: 10.1515/rjim-2016-0045
- tissue_or_cell_type
- Brachial FMD/NMD ratio
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1230–1241
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized placebo crossover vascular trial · source_derived_draft · unverified_draft
### citrulline-cad-ratio The FMD/NMD ratio increased by 0.12 with citrulline versus 0.01 with placebo in the CAD trial. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: A vascular-response ratio improved in this selected patient group. organism: Human, 30 coronary-artery-disease patients tissue_or_cell_type: Brachial FMD/NMD ratio experimental_model: Randomized placebo crossover vascular trial limitations: Small surrogate trial; abstract reports unusual FMD units, so only the dimensionless ratio is extracted. exposure: Fifteen-day L-citrulline and placebo periods evidence_span: {"source_cache": "artifacts/citrulline-research/27648629.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7584e325856443da6067298d1c6ab31b95679839361f4a60adc5f7434944fb17", "start_char": 0, "end_char": 1848, "text_sha256": "7584e325856443da6067298d1c6ab31b95679839361f4a60adc5f7434944fb17"} [citrulline-p27648629] The Assessment of short-term effect of L-Citrulline on endothelial function via FMD to NMD ratio in known CAD patients: A randomized, cross-over clinical trial (Clinical trial number: NCT02638727). (2017). https://pubmed.ncbi.nlm.nih.gov/27648629/ DOI: 10.1515/rjim-2016-0045
Complete structured claim and evidenceAt the largest doses, plasma citrulline accumulated while arginine rose less than expected.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/17953788.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b57ecb5b3484e857904f38ae7c5d5eea51177e2e0a9a9c15ba5f81c2200a11bd", "start_char": 0, "end_char": 1603, "text_sha256": "b57ecb5b3484e857904f38ae7c5d5eea51177e2e0a9a9c15ba5f81c2200a11bd"}
- experimental_model
- Randomized-order oral dose-loading study
- exposure
- Separate 2, 5, 10 and 15 g citrulline loads
- limitations
- Small acute tolerance study; saturation was an interpretation, not directly localized or measured renal enzyme saturation.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, eight healthy fasting men
- plain_language
- More precursor did not yield a proportional arginine increase.
- primary_references
- [citrulline-p17953788] Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study. (2008). https://pubmed.ncbi.nlm.nih.gov/17953788/ DOI: 10.1017/s0007114507841110
- tissue_or_cell_type
- Plasma amino acids and 24-hour urine
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 931–942
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized-order oral dose-loading study · source_derived_draft · unverified_draft
### citrulline-dose-disproportion At the largest doses, plasma citrulline accumulated while arginine rose less than expected. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: More precursor did not yield a proportional arginine increase. organism: Human, eight healthy fasting men tissue_or_cell_type: Plasma amino acids and 24-hour urine experimental_model: Randomized-order oral dose-loading study limitations: Small acute tolerance study; saturation was an interpretation, not directly localized or measured renal enzyme saturation. exposure: Separate 2, 5, 10 and 15 g citrulline loads evidence_span: {"source_cache": "artifacts/citrulline-research/17953788.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b57ecb5b3484e857904f38ae7c5d5eea51177e2e0a9a9c15ba5f81c2200a11bd", "start_char": 0, "end_char": 1603, "text_sha256": "b57ecb5b3484e857904f38ae7c5d5eea51177e2e0a9a9c15ba5f81c2200a11bd"} [citrulline-p17953788] Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study. (2008). https://pubmed.ncbi.nlm.nih.gov/17953788/ DOI: 10.1017/s0007114507841110
Complete structured claim and evidenceNormal-range erection hardness was reported in 12/24 men during citrulline versus 2/24 during the preceding placebo month.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/21195829.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b85dfbc0993e9d8f01bdc021151650d6466c9204a7d7158e488ce66416e1df74", "start_char": 0, "end_char": 1897, "text_sha256": "b85dfbc0993e9d8f01bdc021151650d6466c9204a7d7158e488ce66416e1df74"}
- experimental_model
- Single-blind fixed-sequence placebo then active pilot
- exposure
- One month placebo followed by one month L-citrulline 1.5 g/day
- limitations
- Not a randomized-order crossover; expectation, time and sequence effects cannot be excluded; no direct PDE5-inhibitor comparison.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 24 men with mild erectile dysfunction
- plain_language
- An encouraging pilot finding needs stronger trial confirmation.
- primary_references
- [citrulline-p21195829] Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. (2011). https://pubmed.ncbi.nlm.nih.gov/21195829/ DOI: 10.1016/j.urology.2010.08.028
- tissue_or_cell_type
- Erection hardness
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1243–1254
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Single-blind fixed-sequence placebo then active pilot · source_derived_draft · unverified_draft
### citrulline-erection-pilot Normal-range erection hardness was reported in 12/24 men during citrulline versus 2/24 during the preceding placebo month. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: An encouraging pilot finding needs stronger trial confirmation. organism: Human, 24 men with mild erectile dysfunction tissue_or_cell_type: Erection hardness experimental_model: Single-blind fixed-sequence placebo then active pilot limitations: Not a randomized-order crossover; expectation, time and sequence effects cannot be excluded; no direct PDE5-inhibitor comparison. exposure: One month placebo followed by one month L-citrulline 1.5 g/day evidence_span: {"source_cache": "artifacts/citrulline-research/21195829.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b85dfbc0993e9d8f01bdc021151650d6466c9204a7d7158e488ce66416e1df74", "start_char": 0, "end_char": 1897, "text_sha256": "b85dfbc0993e9d8f01bdc021151650d6466c9204a7d7158e488ce66416e1df74"} [citrulline-p21195829] Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. (2011). https://pubmed.ncbi.nlm.nih.gov/21195829/ DOI: 10.1016/j.urology.2010.08.028
Complete structured claim and evidenceHypoxia and/or inflammation did not reduce citrulline production during the six-hour human explant experiment.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/34882863.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3971162e4b915e3dadb6408a84cf3558526ee837e3446dd61c831f076f3fd901", "start_char": 0, "end_char": 1801, "text_sha256": "3971162e4b915e3dadb6408a84cf3558526ee837e3446dd61c831f076f3fd901"}
- experimental_model
- Six-hour human duodenal explant experiment
- exposure
- Control, hypoxia, inflammation and combined exposure
- limitations
- Short ex-vivo exposure cannot explain all low citrulline in prolonged critical illness; increased utilization remains a proposed explanation.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human biopsies from 25 selected patients
- plain_language
- Low circulating citrulline during illness cannot automatically be attributed to shut-down intestinal production.
- primary_references
- [citrulline-p34882863] Regulation of citrulline synthesis in human enterocytes: Role of hypoxia and inflammation. (2022). https://pubmed.ncbi.nlm.nih.gov/34882863/ DOI: 10.1002/biof.1810
- tissue_or_cell_type
- Intestinal citrulline production
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1022–1033
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Six-hour human duodenal explant experiment · source_derived_draft · unverified_draft
### citrulline-explant-production-null Hypoxia and/or inflammation did not reduce citrulline production during the six-hour human explant experiment. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Low circulating citrulline during illness cannot automatically be attributed to shut-down intestinal production. organism: Human biopsies from 25 selected patients tissue_or_cell_type: Intestinal citrulline production experimental_model: Six-hour human duodenal explant experiment limitations: Short ex-vivo exposure cannot explain all low citrulline in prolonged critical illness; increased utilization remains a proposed explanation. exposure: Control, hypoxia, inflammation and combined exposure evidence_span: {"source_cache": "artifacts/citrulline-research/34882863.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3971162e4b915e3dadb6408a84cf3558526ee837e3446dd61c831f076f3fd901", "start_char": 0, "end_char": 1801, "text_sha256": "3971162e4b915e3dadb6408a84cf3558526ee837e3446dd61c831f076f3fd901"} [citrulline-p34882863] Regulation of citrulline synthesis in human enterocytes: Role of hypoxia and inflammation. (2022). https://pubmed.ncbi.nlm.nih.gov/34882863/ DOI: 10.1002/biof.1810
Complete structured claim and evidenceNo treatment improved FMD over baseline in the healthy-volunteer study.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/17662090.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b", "start_char": 0, "end_char": 1980, "text_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b"}
- experimental_model
- Double-blind placebo-controlled crossover study
- exposure
- Citrulline 0.75, 1.5 or 3 g twice daily versus arginine formulations; one-week periods
- limitations
- Small short trial; NO-related urine markers do not establish a clinically meaningful vascular benefit.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 20 healthy volunteers
- plain_language
- Better precursor exposure did not produce a detectable improvement in this vascular endpoint.
- primary_references
- [citrulline-p17662090] Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. (2008). https://pubmed.ncbi.nlm.nih.gov/17662090/ DOI: 10.1111/j.1365-2125.2007.02990.x
- tissue_or_cell_type
- Plasma amino acids, urine NO markers and brachial FMD
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 918–929
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind placebo-controlled crossover study · source_derived_draft · unverified_draft
### citrulline-healthy-fmd-null No treatment improved FMD over baseline in the healthy-volunteer study. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Better precursor exposure did not produce a detectable improvement in this vascular endpoint. organism: Human, 20 healthy volunteers tissue_or_cell_type: Plasma amino acids, urine NO markers and brachial FMD experimental_model: Double-blind placebo-controlled crossover study limitations: Small short trial; NO-related urine markers do not establish a clinically meaningful vascular benefit. exposure: Citrulline 0.75, 1.5 or 3 g twice daily versus arginine formulations; one-week periods evidence_span: {"source_cache": "artifacts/citrulline-research/17662090.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b", "start_char": 0, "end_char": 1980, "text_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b"} [citrulline-p17662090] Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. (2008). https://pubmed.ncbi.nlm.nih.gov/17662090/ DOI: 10.1111/j.1365-2125.2007.02990.x
Complete structured claim and evidencePlasma insulin and growth hormone were not affected by the oral citrulline loads.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/17953788.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b57ecb5b3484e857904f38ae7c5d5eea51177e2e0a9a9c15ba5f81c2200a11bd", "start_char": 0, "end_char": 1603, "text_sha256": "b57ecb5b3484e857904f38ae7c5d5eea51177e2e0a9a9c15ba5f81c2200a11bd"}
- experimental_model
- Randomized-order oral dose-loading study
- exposure
- Separate 2, 5, 10 and 15 g citrulline loads
- limitations
- Small acute tolerance study; saturation was an interpretation, not directly localized or measured renal enzyme saturation.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, eight healthy fasting men
- plain_language
- The study did not show a growth-hormone or insulin boost.
- primary_references
- [citrulline-p17953788] Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study. (2008). https://pubmed.ncbi.nlm.nih.gov/17953788/ DOI: 10.1017/s0007114507841110
- tissue_or_cell_type
- Plasma amino acids and 24-hour urine
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 957–968
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized-order oral dose-loading study · source_derived_draft · unverified_draft
### citrulline-hormone-null Plasma insulin and growth hormone were not affected by the oral citrulline loads. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The study did not show a growth-hormone or insulin boost. organism: Human, eight healthy fasting men tissue_or_cell_type: Plasma amino acids and 24-hour urine experimental_model: Randomized-order oral dose-loading study limitations: Small acute tolerance study; saturation was an interpretation, not directly localized or measured renal enzyme saturation. exposure: Separate 2, 5, 10 and 15 g citrulline loads evidence_span: {"source_cache": "artifacts/citrulline-research/17953788.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b57ecb5b3484e857904f38ae7c5d5eea51177e2e0a9a9c15ba5f81c2200a11bd", "start_char": 0, "end_char": 1603, "text_sha256": "b57ecb5b3484e857904f38ae7c5d5eea51177e2e0a9a9c15ba5f81c2200a11bd"} [citrulline-p17953788] Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study. (2008). https://pubmed.ncbi.nlm.nih.gov/17953788/ DOI: 10.1017/s0007114507841110
Complete structured claim and evidenceMixed-muscle fractional synthesis was higher with citrulline than the comparator, 0.060 versus 0.049, P=0.03.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/24972455.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "766ca1c6460f11fb78c1f94c02e42f53bf30269e7368cd62e0518e976e2b2995", "start_char": 0, "end_char": 1703, "text_sha256": "766ca1c6460f11fb78c1f94c02e42f53bf30269e7368cd62e0518e976e2b2995"}
- experimental_model
- Crossover isotope muscle-protein synthesis pilot
- exposure
- Oral citrulline versus a nonessential-amino-acid mixture over eight hours
- limitations
- Acute fractional synthesis is not long-term muscle growth; participants were not representative of all malnourished or older people.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, eight healthy adults after three days of low protein intake
- plain_language
- One muscle protein measure improved after a short low-protein diet.
- primary_references
- [citrulline-p24972455] Citrulline stimulates muscle protein synthesis in the post-absorptive state in healthy people fed a low-protein diet - A pilot study. (2015). https://pubmed.ncbi.nlm.nih.gov/24972455/ DOI: 10.1016/j.clnu.2014.04.019
- tissue_or_cell_type
- Mixed and mitochondrial muscle protein fractions
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1035–1046
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Crossover isotope muscle-protein synthesis pilot · source_derived_draft · unverified_draft
### citrulline-low-protein-mps Mixed-muscle fractional synthesis was higher with citrulline than the comparator, 0.060 versus 0.049, P=0.03. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: One muscle protein measure improved after a short low-protein diet. organism: Human, eight healthy adults after three days of low protein intake tissue_or_cell_type: Mixed and mitochondrial muscle protein fractions experimental_model: Crossover isotope muscle-protein synthesis pilot limitations: Acute fractional synthesis is not long-term muscle growth; participants were not representative of all malnourished or older people. exposure: Oral citrulline versus a nonessential-amino-acid mixture over eight hours evidence_span: {"source_cache": "artifacts/citrulline-research/24972455.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "766ca1c6460f11fb78c1f94c02e42f53bf30269e7368cd62e0518e976e2b2995", "start_char": 0, "end_char": 1703, "text_sha256": "766ca1c6460f11fb78c1f94c02e42f53bf30269e7368cd62e0518e976e2b2995"} [citrulline-p24972455] Citrulline stimulates muscle protein synthesis in the post-absorptive state in healthy people fed a low-protein diet - A pilot study. (2015). https://pubmed.ncbi.nlm.nih.gov/24972455/ DOI: 10.1016/j.clnu.2014.04.019
Complete structured claim and evidenceCitrulline plasma increments after oral loads were similar in LPI homozygotes and controls, unlike diamino-acid increments.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/citrulline-research/6776014.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6db6a42e66322b8ae26335a4f51284ede7691dcbb91e8cf7d7cd6671bd41b87d", "start_char": 0, "end_char": 1189, "text_sha256": "6db6a42e66322b8ae26335a4f51284ede7691dcbb91e8cf7d7cd6671bd41b87d"}
- experimental_model
- Oral amino-acid loading comparison
- exposure
- Separate diamino-acid and citrulline loads
- limitations
- Inherited transport disorder, not ordinary competition from mixed dietary protein; the study predates gene identification.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human LPI patients, heterozygotes and controls
- plain_language
- A different entry route can bypass this particular transport problem.
- primary_references
- [citrulline-p6776014] Intestinal absorption in lysinuric protein intolerance: impaired for diamino acids, normal for citrulline. (1980). https://pubmed.ncbi.nlm.nih.gov/6776014/ DOI: 10.1136/gut.21.6.519
- tissue_or_cell_type
- Intestinal amino-acid absorption inferred from plasma and urine
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 840–851
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Oral amino-acid loading comparison · source_derived_draft · unverified_draft
### citrulline-lpi-citrulline-absorption Citrulline plasma increments after oral loads were similar in LPI homozygotes and controls, unlike diamino-acid increments. Condition category: machinery_impairment nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: A different entry route can bypass this particular transport problem. organism: Human LPI patients, heterozygotes and controls tissue_or_cell_type: Intestinal amino-acid absorption inferred from plasma and urine experimental_model: Oral amino-acid loading comparison limitations: Inherited transport disorder, not ordinary competition from mixed dietary protein; the study predates gene identification. exposure: Separate diamino-acid and citrulline loads evidence_span: {"source_cache": "artifacts/citrulline-research/6776014.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6db6a42e66322b8ae26335a4f51284ede7691dcbb91e8cf7d7cd6671bd41b87d", "start_char": 0, "end_char": 1189, "text_sha256": "6db6a42e66322b8ae26335a4f51284ede7691dcbb91e8cf7d7cd6671bd41b87d"} [citrulline-p6776014] Intestinal absorption in lysinuric protein intolerance: impaired for diamino acids, normal for citrulline. (1980). https://pubmed.ncbi.nlm.nih.gov/6776014/ DOI: 10.1136/gut.21.6.519
Complete structured claim and evidenceOral citrulline raised plasma urea-cycle intermediates more than oral arginine or ornithine in the LPI report.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/6401349.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e98ad3132221fd0deae9dd89d6c14a4f6b010655656a6e0ea44a7c47f2ca1545", "start_char": 0, "end_char": 349, "text_sha256": "e98ad3132221fd0deae9dd89d6c14a4f6b010655656a6e0ea44a7c47f2ca1545"}
- experimental_model
- Clinical oral-intermediate comparison
- exposure
- Oral citrulline, arginine or ornithine
- limitations
- Brief indexed abstract; no trial size or dosing is inferred; not evidence that citrulline replaces lysine.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human lysinuric protein intolerance
- plain_language
- The alternative precursor improved downstream amino-acid availability in this disorder.
- primary_references
- [citrulline-p6401349] Oral administration of urea cycle intermediates in lysinuric protein intolerance: effect on plasma and urinary arginine and ornithine. (1983). https://pubmed.ncbi.nlm.nih.gov/6401349/ DOI: 10.1016/0026-0495(83)90154-3
- tissue_or_cell_type
- Plasma urea-cycle intermediates
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 853–864
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Clinical oral-intermediate comparison · source_derived_draft · unverified_draft
### citrulline-lpi-precursor-response Oral citrulline raised plasma urea-cycle intermediates more than oral arginine or ornithine in the LPI report. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The alternative precursor improved downstream amino-acid availability in this disorder. organism: Human lysinuric protein intolerance tissue_or_cell_type: Plasma urea-cycle intermediates experimental_model: Clinical oral-intermediate comparison limitations: Brief indexed abstract; no trial size or dosing is inferred; not evidence that citrulline replaces lysine. exposure: Oral citrulline, arginine or ornithine evidence_span: {"source_cache": "artifacts/citrulline-research/6401349.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e98ad3132221fd0deae9dd89d6c14a4f6b010655656a6e0ea44a7c47f2ca1545", "start_char": 0, "end_char": 349, "text_sha256": "e98ad3132221fd0deae9dd89d6c14a4f6b010655656a6e0ea44a7c47f2ca1545"} [citrulline-p6401349] Oral administration of urea cycle intermediates in lysinuric protein intolerance: effect on plasma and urinary arginine and ornithine. (1983). https://pubmed.ncbi.nlm.nih.gov/6401349/ DOI: 10.1016/0026-0495(83)90154-3
Complete structured claim and evidenceMatched-dose L-citrulline did not improve maximal neuromuscular or ballistic performance versus placebo.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/39662304.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3f26c60b31d2021fb82143a4780ab4437e58c18d1c482a0880fdc4321f224092", "start_char": 0, "end_char": 1816, "text_sha256": "3f26c60b31d2021fb82143a4780ab4437e58c18d1c482a0880fdc4321f224092"}
- experimental_model
- Randomized double-blind placebo-controlled crossover trial
- exposure
- 5.3 g L-citrulline; or 5.3 g citrulline plus 2.7 g malate; or placebo 45 minutes pre-exercise
- limitations
- Acute low-to-moderate-volume protocol; not a universal finding for all doses, workouts or chronic use.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 43 trained adults including 21 women
- plain_language
- The pure amino acid did not produce a measurable advantage here.
- primary_references
- [citrulline-p39662304] Malate or Not? Acute Effects of L-Citrulline Versus Citrulline Malate on Neuromuscular Performance in Young, Trained Adults: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial. (2025). https://pubmed.ncbi.nlm.nih.gov/39662304/ DOI: 10.1123/ijsnem.2024-0006
- tissue_or_cell_type
- Neuromuscular, ballistic and strength-endurance tests
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1178–1189
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind placebo-controlled crossover trial · source_derived_draft · unverified_draft
### citrulline-matched-pure-null Matched-dose L-citrulline did not improve maximal neuromuscular or ballistic performance versus placebo. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The pure amino acid did not produce a measurable advantage here. organism: Human, 43 trained adults including 21 women tissue_or_cell_type: Neuromuscular, ballistic and strength-endurance tests experimental_model: Randomized double-blind placebo-controlled crossover trial limitations: Acute low-to-moderate-volume protocol; not a universal finding for all doses, workouts or chronic use. exposure: 5.3 g L-citrulline; or 5.3 g citrulline plus 2.7 g malate; or placebo 45 minutes pre-exercise evidence_span: {"source_cache": "artifacts/citrulline-research/39662304.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3f26c60b31d2021fb82143a4780ab4437e58c18d1c482a0880fdc4321f224092", "start_char": 0, "end_char": 1816, "text_sha256": "3f26c60b31d2021fb82143a4780ab4437e58c18d1c482a0880fdc4321f224092"} [citrulline-p39662304] Malate or Not? Acute Effects of L-Citrulline Versus Citrulline Malate on Neuromuscular Performance in Young, Trained Adults: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial. (2025). https://pubmed.ncbi.nlm.nih.gov/39662304/ DOI: 10.1123/ijsnem.2024-0006
Complete structured claim and evidenceMitochondrial protein synthesis and whole-body protein turnover did not differ between treatments.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/24972455.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "766ca1c6460f11fb78c1f94c02e42f53bf30269e7368cd62e0518e976e2b2995", "start_char": 0, "end_char": 1703, "text_sha256": "766ca1c6460f11fb78c1f94c02e42f53bf30269e7368cd62e0518e976e2b2995"}
- experimental_model
- Crossover isotope muscle-protein synthesis pilot
- exposure
- Oral citrulline versus a nonessential-amino-acid mixture over eight hours
- limitations
- Acute fractional synthesis is not long-term muscle growth; participants were not representative of all malnourished or older people.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, eight healthy adults after three days of low protein intake
- plain_language
- The anabolic result did not apply to every protein compartment.
- primary_references
- [citrulline-p24972455] Citrulline stimulates muscle protein synthesis in the post-absorptive state in healthy people fed a low-protein diet - A pilot study. (2015). https://pubmed.ncbi.nlm.nih.gov/24972455/ DOI: 10.1016/j.clnu.2014.04.019
- tissue_or_cell_type
- Mixed and mitochondrial muscle protein fractions
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1048–1059
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Crossover isotope muscle-protein synthesis pilot · source_derived_draft · unverified_draft
### citrulline-mitochondrial-mps-null Mitochondrial protein synthesis and whole-body protein turnover did not differ between treatments. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The anabolic result did not apply to every protein compartment. organism: Human, eight healthy adults after three days of low protein intake tissue_or_cell_type: Mixed and mitochondrial muscle protein fractions experimental_model: Crossover isotope muscle-protein synthesis pilot limitations: Acute fractional synthesis is not long-term muscle growth; participants were not representative of all malnourished or older people. exposure: Oral citrulline versus a nonessential-amino-acid mixture over eight hours evidence_span: {"source_cache": "artifacts/citrulline-research/24972455.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "766ca1c6460f11fb78c1f94c02e42f53bf30269e7368cd62e0518e976e2b2995", "start_char": 0, "end_char": 1703, "text_sha256": "766ca1c6460f11fb78c1f94c02e42f53bf30269e7368cd62e0518e976e2b2995"} [citrulline-p24972455] Citrulline stimulates muscle protein synthesis in the post-absorptive state in healthy people fed a low-protein diet - A pilot study. (2015). https://pubmed.ncbi.nlm.nih.gov/24972455/ DOI: 10.1016/j.clnu.2014.04.019
Complete structured claim and evidenceAdding citrulline to 15 g whey did not augment myofibrillar protein synthesis compared with the nonessential-amino-acid addition.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/24824653.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3c9cb88e6978c602b77415910ae94823f258788387d0623bfe89af339fed5ebb", "start_char": 0, "end_char": 1815, "text_sha256": "3c9cb88e6978c602b77415910ae94823f258788387d0623bfe89af339fed5ebb"}
- experimental_model
- Postexercise feeding and tracer study
- exposure
- 15 g whey plus 10 g citrulline or nonessential amino acids; comparator 45 g whey
- limitations
- Different population, protein background and protein fraction from the low-protein pilot; no automatic claim of contradiction.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 21 men aged 65-80
- plain_language
- Citrulline did not substitute for a larger protein meal in this trial.
- primary_references
- [citrulline-p24824653] Citrulline does not enhance blood flow, microvascular circulation, or myofibrillar protein synthesis in elderly men at rest or following exercise. (2014). https://pubmed.ncbi.nlm.nih.gov/24824653/ DOI: 10.1152/ajpendo.00096.2014
- tissue_or_cell_type
- Rested and exercised skeletal muscle
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1061–1072
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Postexercise feeding and tracer study · source_derived_draft · unverified_draft
### citrulline-older-mps-null Adding citrulline to 15 g whey did not augment myofibrillar protein synthesis compared with the nonessential-amino-acid addition. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Citrulline did not substitute for a larger protein meal in this trial. organism: Human, 21 men aged 65-80 tissue_or_cell_type: Rested and exercised skeletal muscle experimental_model: Postexercise feeding and tracer study limitations: Different population, protein background and protein fraction from the low-protein pilot; no automatic claim of contradiction. exposure: 15 g whey plus 10 g citrulline or nonessential amino acids; comparator 45 g whey evidence_span: {"source_cache": "artifacts/citrulline-research/24824653.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3c9cb88e6978c602b77415910ae94823f258788387d0623bfe89af339fed5ebb", "start_char": 0, "end_char": 1815, "text_sha256": "3c9cb88e6978c602b77415910ae94823f258788387d0623bfe89af339fed5ebb"} [citrulline-p24824653] Citrulline does not enhance blood flow, microvascular circulation, or myofibrillar protein synthesis in elderly men at rest or following exercise. (2014). https://pubmed.ncbi.nlm.nih.gov/24824653/ DOI: 10.1152/ajpendo.00096.2014
Complete structured claim and evidenceDespite higher arginine, blood flow and muscle microvascular perfusion did not differ between treatments.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/24824653.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3c9cb88e6978c602b77415910ae94823f258788387d0623bfe89af339fed5ebb", "start_char": 0, "end_char": 1815, "text_sha256": "3c9cb88e6978c602b77415910ae94823f258788387d0623bfe89af339fed5ebb"}
- experimental_model
- Postexercise feeding and tracer study
- exposure
- 15 g whey plus 10 g citrulline or nonessential amino acids; comparator 45 g whey
- limitations
- Different population, protein background and protein fraction from the low-protein pilot; no automatic claim of contradiction.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 21 men aged 65-80
- plain_language
- Higher blood arginine was not enough to improve measured muscle perfusion.
- primary_references
- [citrulline-p24824653] Citrulline does not enhance blood flow, microvascular circulation, or myofibrillar protein synthesis in elderly men at rest or following exercise. (2014). https://pubmed.ncbi.nlm.nih.gov/24824653/ DOI: 10.1152/ajpendo.00096.2014
- tissue_or_cell_type
- Rested and exercised skeletal muscle
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1074–1085
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Postexercise feeding and tracer study · source_derived_draft · unverified_draft
### citrulline-older-perfusion-null Despite higher arginine, blood flow and muscle microvascular perfusion did not differ between treatments. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Higher blood arginine was not enough to improve measured muscle perfusion. organism: Human, 21 men aged 65-80 tissue_or_cell_type: Rested and exercised skeletal muscle experimental_model: Postexercise feeding and tracer study limitations: Different population, protein background and protein fraction from the low-protein pilot; no automatic claim of contradiction. exposure: 15 g whey plus 10 g citrulline or nonessential amino acids; comparator 45 g whey evidence_span: {"source_cache": "artifacts/citrulline-research/24824653.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3c9cb88e6978c602b77415910ae94823f258788387d0623bfe89af339fed5ebb", "start_char": 0, "end_char": 1815, "text_sha256": "3c9cb88e6978c602b77415910ae94823f258788387d0623bfe89af339fed5ebb"} [citrulline-p24824653] Citrulline does not enhance blood flow, microvascular circulation, or myofibrillar protein synthesis in elderly men at rest or following exercise. (2014). https://pubmed.ncbi.nlm.nih.gov/24824653/ DOI: 10.1152/ajpendo.00096.2014
Complete structured claim and evidenceOral citrulline increased plasma arginine AUC and peak concentration dose-dependently, more effectively than the tested oral arginine regimens.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/17662090.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b", "start_char": 0, "end_char": 1980, "text_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b"}
- experimental_model
- Double-blind placebo-controlled crossover study
- exposure
- Citrulline 0.75, 1.5 or 3 g twice daily versus arginine formulations; one-week periods
- limitations
- Small short trial; NO-related urine markers do not establish a clinically meaningful vascular benefit.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 20 healthy volunteers
- plain_language
- Taking the precursor can raise circulating arginine efficiently.
- primary_references
- [citrulline-p17662090] Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. (2008). https://pubmed.ncbi.nlm.nih.gov/17662090/ DOI: 10.1111/j.1365-2125.2007.02990.x
- tissue_or_cell_type
- Plasma amino acids, urine NO markers and brachial FMD
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 866–877
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind placebo-controlled crossover study · source_derived_draft · unverified_draft
### citrulline-oral-arginine Oral citrulline increased plasma arginine AUC and peak concentration dose-dependently, more effectively than the tested oral arginine regimens. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Taking the precursor can raise circulating arginine efficiently. organism: Human, 20 healthy volunteers tissue_or_cell_type: Plasma amino acids, urine NO markers and brachial FMD experimental_model: Double-blind placebo-controlled crossover study limitations: Small short trial; NO-related urine markers do not establish a clinically meaningful vascular benefit. exposure: Citrulline 0.75, 1.5 or 3 g twice daily versus arginine formulations; one-week periods evidence_span: {"source_cache": "artifacts/citrulline-research/17662090.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b", "start_char": 0, "end_char": 1980, "text_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b"} [citrulline-p17662090] Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. (2008). https://pubmed.ncbi.nlm.nih.gov/17662090/ DOI: 10.1111/j.1365-2125.2007.02990.x
Complete structured claim and evidenceWalking-distance change was 20.11% with citrulline versus 5.73% with placebo, P=0.011.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/39985883.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c", "start_char": 0, "end_char": 1888, "text_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c"}
- experimental_model
- Phase II double-blind placebo-controlled crossover trial
- exposure
- 3 g citrulline twice daily for 12 weeks; additional BH4 0.45 g/day for two weeks in one arm
- limitations
- Preliminary trial; subgroup-dependent BH4 result and study-specific ADMA cutoff require confirmation; not a general supplement prescription.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 51 peripheral-artery-disease patients
- plain_language
- A patient-relevant walking endpoint improved in this preliminary PAD trial.
- primary_references
- [citrulline-p39985883] Nutritional L-Citrulline and Tetrahydrobiopterin in Peripheral Artery Disease: A Phase II Randomized Trial (CIPER Study). (2025). https://pubmed.ncbi.nlm.nih.gov/39985883/ DOI: 10.1016/j.jacadv.2025.101590
- tissue_or_cell_type
- Absolute claudication distance and plasma biomarkers
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1204–1215
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Phase II double-blind placebo-controlled crossover trial · source_derived_draft · unverified_draft
### citrulline-pad-walking Walking-distance change was 20.11% with citrulline versus 5.73% with placebo, P=0.011. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: A patient-relevant walking endpoint improved in this preliminary PAD trial. organism: Human, 51 peripheral-artery-disease patients tissue_or_cell_type: Absolute claudication distance and plasma biomarkers experimental_model: Phase II double-blind placebo-controlled crossover trial limitations: Preliminary trial; subgroup-dependent BH4 result and study-specific ADMA cutoff require confirmation; not a general supplement prescription. exposure: 3 g citrulline twice daily for 12 weeks; additional BH4 0.45 g/day for two weeks in one arm evidence_span: {"source_cache": "artifacts/citrulline-research/39985883.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c", "start_char": 0, "end_char": 1888, "text_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c"} [citrulline-p39985883] Nutritional L-Citrulline and Tetrahydrobiopterin in Peripheral Artery Disease: A Phase II Randomized Trial (CIPER Study). (2025). https://pubmed.ncbi.nlm.nih.gov/39985883/ DOI: 10.1016/j.jacadv.2025.101590
Complete structured claim and evidenceBoth oral and intravenous citrulline groups showed increased bacterial burden and inflammation.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/38825026.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a41a36f1d4539b1bb87cbfbd145f54655183855c1a4ad0061589bee0c13df062", "start_char": 0, "end_char": 1404, "text_sha256": "a41a36f1d4539b1bb87cbfbd145f54655183855c1a4ad0061589bee0c13df062"}
- experimental_model
- Controlled infection experiment with oral or intravenous supplementation
- exposure
- Citrulline 1 g/kg followed by Staphylococcus epidermidis inoculation; 14-hour monitoring
- limitations
- Preclinical high-exposure neonatal infection model; does not establish harm from usual adult supplementation or benefit in human sepsis.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Preterm pigs; related cord-blood experiments
- plain_language
- Effects on immunity and timing can matter beyond the NO pathway.
- primary_references
- [citrulline-p38825026] Citrulline supplementation exacerbates sepsis severity in infected preterm piglets via early induced immunosuppression. (2024). https://pubmed.ncbi.nlm.nih.gov/38825026/ DOI: 10.1016/j.jnutbio.2024.109674
- tissue_or_cell_type
- Bacterial load, inflammation and survival
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1269–1280
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Controlled infection experiment with oral or intravenous supplementation · source_derived_draft · unverified_draft
### citrulline-preterm-sepsis-burden Both oral and intravenous citrulline groups showed increased bacterial burden and inflammation. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Effects on immunity and timing can matter beyond the NO pathway. organism: Preterm pigs; related cord-blood experiments tissue_or_cell_type: Bacterial load, inflammation and survival experimental_model: Controlled infection experiment with oral or intravenous supplementation limitations: Preclinical high-exposure neonatal infection model; does not establish harm from usual adult supplementation or benefit in human sepsis. exposure: Citrulline 1 g/kg followed by Staphylococcus epidermidis inoculation; 14-hour monitoring evidence_span: {"source_cache": "artifacts/citrulline-research/38825026.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a41a36f1d4539b1bb87cbfbd145f54655183855c1a4ad0061589bee0c13df062", "start_char": 0, "end_char": 1404, "text_sha256": "a41a36f1d4539b1bb87cbfbd145f54655183855c1a4ad0061589bee0c13df062"} [citrulline-p38825026] Citrulline supplementation exacerbates sepsis severity in infected preterm piglets via early induced immunosuppression. (2024). https://pubmed.ncbi.nlm.nih.gov/38825026/ DOI: 10.1016/j.jnutbio.2024.109674
Complete structured claim and evidenceOral citrulline increased mortality in infected preterm pigs; intravenous exposure did not significantly change mortality.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/38825026.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a41a36f1d4539b1bb87cbfbd145f54655183855c1a4ad0061589bee0c13df062", "start_char": 0, "end_char": 1404, "text_sha256": "a41a36f1d4539b1bb87cbfbd145f54655183855c1a4ad0061589bee0c13df062"}
- experimental_model
- Controlled infection experiment with oral or intravenous supplementation
- exposure
- Citrulline 1 g/kg followed by Staphylococcus epidermidis inoculation; 14-hour monitoring
- limitations
- Preclinical high-exposure neonatal infection model; does not establish harm from usual adult supplementation or benefit in human sepsis.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Preterm pigs; related cord-blood experiments
- plain_language
- Correcting a presumed precursor shortage did not improve this infection model.
- primary_references
- [citrulline-p38825026] Citrulline supplementation exacerbates sepsis severity in infected preterm piglets via early induced immunosuppression. (2024). https://pubmed.ncbi.nlm.nih.gov/38825026/ DOI: 10.1016/j.jnutbio.2024.109674
- tissue_or_cell_type
- Bacterial load, inflammation and survival
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1256–1267
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Controlled infection experiment with oral or intravenous supplementation · source_derived_draft · unverified_draft
### citrulline-preterm-sepsis-mortality Oral citrulline increased mortality in infected preterm pigs; intravenous exposure did not significantly change mortality. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Correcting a presumed precursor shortage did not improve this infection model. organism: Preterm pigs; related cord-blood experiments tissue_or_cell_type: Bacterial load, inflammation and survival experimental_model: Controlled infection experiment with oral or intravenous supplementation limitations: Preclinical high-exposure neonatal infection model; does not establish harm from usual adult supplementation or benefit in human sepsis. exposure: Citrulline 1 g/kg followed by Staphylococcus epidermidis inoculation; 14-hour monitoring evidence_span: {"source_cache": "artifacts/citrulline-research/38825026.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a41a36f1d4539b1bb87cbfbd145f54655183855c1a4ad0061589bee0c13df062", "start_char": 0, "end_char": 1404, "text_sha256": "a41a36f1d4539b1bb87cbfbd145f54655183855c1a4ad0061589bee0c13df062"} [citrulline-p38825026] Citrulline supplementation exacerbates sepsis severity in infected preterm piglets via early induced immunosuppression. (2024). https://pubmed.ncbi.nlm.nih.gov/38825026/ DOI: 10.1016/j.jnutbio.2024.109674
Complete structured claim and evidenceDespite reduced renal function, whole-body de novo arginine synthesis appeared preserved in the ESRD patients.
Experimental context and source evidence
- availability_state
- biomarker_context Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/citrulline-research/10791996.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "80c58ac3892fcee1c04da2c05c0005b4b40e6c3479127a3da3528e46162c7f49", "start_char": 0, "end_char": 1285, "text_sha256": "80c58ac3892fcee1c04da2c05c0005b4b40e6c3479127a3da3528e46162c7f49"}
- experimental_model
- Stable-isotope kinetic study around hemodialysis
- exposure
- Two pre- and two postdialysis tracer studies
- limitations
- Whole-body flux does not locate the compensating tissues; elevated plasma concentration is not evidence of adequate function in every compartment.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, six end-stage renal disease patients
- plain_language
- Loss of kidney function did not abolish all arginine synthesis in this small study.
- primary_references
- [citrulline-p10791996] Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients. (2000). https://pubmed.ncbi.nlm.nih.gov/10791996/ DOI: 10.1172/jci7199
- tissue_or_cell_type
- Whole-body arginine and NO metabolism
- trigger_kind
- biomarker_context Imported condition classification; unverified.
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1009–1020
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Stable-isotope kinetic study around hemodialysis · source_derived_draft · unverified_draft
### citrulline-renal-arginine-preserved Despite reduced renal function, whole-body de novo arginine synthesis appeared preserved in the ESRD patients. Condition category: biomarker_context nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Loss of kidney function did not abolish all arginine synthesis in this small study. organism: Human, six end-stage renal disease patients tissue_or_cell_type: Whole-body arginine and NO metabolism experimental_model: Stable-isotope kinetic study around hemodialysis limitations: Whole-body flux does not locate the compensating tissues; elevated plasma concentration is not evidence of adequate function in every compartment. exposure: Two pre- and two postdialysis tracer studies evidence_span: {"source_cache": "artifacts/citrulline-research/10791996.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "80c58ac3892fcee1c04da2c05c0005b4b40e6c3479127a3da3528e46162c7f49", "start_char": 0, "end_char": 1285, "text_sha256": "80c58ac3892fcee1c04da2c05c0005b4b40e6c3479127a3da3528e46162c7f49"} [citrulline-p10791996] Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients. (2000). https://pubmed.ncbi.nlm.nih.gov/10791996/ DOI: 10.1172/jci7199
Complete structured claim and evidenceThe kidneys accounted for 75% of whole-body arginine production from citrulline in the isotope study.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/25332337.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d517656dd9033a9df73e29b10d07fdccbc7c369155450ba662fe006d045cf4d0", "start_char": 0, "end_char": 1788, "text_sha256": "d517656dd9033a9df73e29b10d07fdccbc7c369155450ba662fe006d045cf4d0"}
- experimental_model
- Stable-isotope whole-body and renal balance study
- exposure
- Perioperative intravenous alanyl-glutamine 0.5 g/kg/day
- limitations
- Small perioperative study; the reported doubling versus previous studies was not a concurrent randomized control comparison.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, seven surgical patients
- plain_language
- The kidney is a major conversion site, but it is not the only possible site.
- primary_references
- [citrulline-p25332337] Intravenous glutamine supplementation enhances renal de novo arginine synthesis in humans: a stable isotope study. (2014). https://pubmed.ncbi.nlm.nih.gov/25332337/ DOI: 10.3945/ajcn.113.081547
- tissue_or_cell_type
- Intestinal-renal amino-acid axis
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 450–461
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Stable-isotope whole-body and renal balance study · source_derived_draft · unverified_draft
### citrulline-renal-conversion The kidneys accounted for 75% of whole-body arginine production from citrulline in the isotope study. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The kidney is a major conversion site, but it is not the only possible site. organism: Human, seven surgical patients tissue_or_cell_type: Intestinal-renal amino-acid axis experimental_model: Stable-isotope whole-body and renal balance study limitations: Small perioperative study; the reported doubling versus previous studies was not a concurrent randomized control comparison. exposure: Perioperative intravenous alanyl-glutamine 0.5 g/kg/day evidence_span: {"source_cache": "artifacts/citrulline-research/25332337.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d517656dd9033a9df73e29b10d07fdccbc7c369155450ba662fe006d045cf4d0", "start_char": 0, "end_char": 1788, "text_sha256": "d517656dd9033a9df73e29b10d07fdccbc7c369155450ba662fe006d045cf4d0"} [citrulline-p25332337] Intravenous glutamine supplementation enhances renal de novo arginine synthesis in humans: a stable isotope study. (2014). https://pubmed.ncbi.nlm.nih.gov/25332337/ DOI: 10.3945/ajcn.113.081547
Complete structured claim and evidenceESRD patients had elevated plasma citrulline and citrulline flux compared with healthy adults.
Experimental context and source evidence
- availability_state
- biomarker_context Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/citrulline-research/10791996.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "80c58ac3892fcee1c04da2c05c0005b4b40e6c3479127a3da3528e46162c7f49", "start_char": 0, "end_char": 1285, "text_sha256": "80c58ac3892fcee1c04da2c05c0005b4b40e6c3479127a3da3528e46162c7f49"}
- experimental_model
- Stable-isotope kinetic study around hemodialysis
- exposure
- Two pre- and two postdialysis tracer studies
- limitations
- Whole-body flux does not locate the compensating tissues; elevated plasma concentration is not evidence of adequate function in every compartment.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, six end-stage renal disease patients
- plain_language
- A high value can coexist with severe kidney disease.
- primary_references
- [citrulline-p10791996] Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients. (2000). https://pubmed.ncbi.nlm.nih.gov/10791996/ DOI: 10.1172/jci7199
- tissue_or_cell_type
- Whole-body arginine and NO metabolism
- trigger_kind
- biomarker_context Imported condition classification; unverified.
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 996–1007
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Stable-isotope kinetic study around hemodialysis · source_derived_draft · unverified_draft
### citrulline-renal-high-citrulline ESRD patients had elevated plasma citrulline and citrulline flux compared with healthy adults. Condition category: biomarker_context nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: A high value can coexist with severe kidney disease. organism: Human, six end-stage renal disease patients tissue_or_cell_type: Whole-body arginine and NO metabolism experimental_model: Stable-isotope kinetic study around hemodialysis limitations: Whole-body flux does not locate the compensating tissues; elevated plasma concentration is not evidence of adequate function in every compartment. exposure: Two pre- and two postdialysis tracer studies evidence_span: {"source_cache": "artifacts/citrulline-research/10791996.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "80c58ac3892fcee1c04da2c05c0005b4b40e6c3479127a3da3528e46162c7f49", "start_char": 0, "end_char": 1285, "text_sha256": "80c58ac3892fcee1c04da2c05c0005b4b40e6c3479127a3da3528e46162c7f49"} [citrulline-p10791996] Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients. (2000). https://pubmed.ncbi.nlm.nih.gov/10791996/ DOI: 10.1172/jci7199
Complete structured claim and evidenceCitrulline supplementation increased plasma citrulline seventeenfold and arginine threefold in the SBS trial.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/30642738.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0d8869660890cdf77bcc2056b8871bc7be2b4828791a4681c87657a8efe42737", "start_char": 0, "end_char": 2343, "text_sha256": "0d8869660890cdf77bcc2056b8871bc7be2b4828791a4681c87657a8efe42737"}
- experimental_model
- Double-blind crossover isotope study
- exposure
- 0.18 g/kg/day citrulline for seven days versus isonitrogenous placebo
- limitations
- Near-normal nutritional status long after surgery; exploratory low-baseline subgroups were too small for a treatment rule.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, nine adults with stable nonmalignant short-bowel syndrome
- plain_language
- The oral precursor reached blood and increased downstream arginine.
- primary_references
- [citrulline-p30642738] Effect of oral citrulline supplementation on whole body protein metabolism in adult patients with short bowel syndrome: A pilot, randomized, double-blind, cross-over study. (2019). https://pubmed.ncbi.nlm.nih.gov/30642738/ DOI: 10.1016/j.clnu.2018.12.030
- tissue_or_cell_type
- Whole-body protein metabolism
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1087–1098
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind crossover isotope study · source_derived_draft · unverified_draft
### citrulline-sbs-exposure Citrulline supplementation increased plasma citrulline seventeenfold and arginine threefold in the SBS trial. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The oral precursor reached blood and increased downstream arginine. organism: Human, nine adults with stable nonmalignant short-bowel syndrome tissue_or_cell_type: Whole-body protein metabolism experimental_model: Double-blind crossover isotope study limitations: Near-normal nutritional status long after surgery; exploratory low-baseline subgroups were too small for a treatment rule. exposure: 0.18 g/kg/day citrulline for seven days versus isonitrogenous placebo evidence_span: {"source_cache": "artifacts/citrulline-research/30642738.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0d8869660890cdf77bcc2056b8871bc7be2b4828791a4681c87657a8efe42737", "start_char": 0, "end_char": 2343, "text_sha256": "0d8869660890cdf77bcc2056b8871bc7be2b4828791a4681c87657a8efe42737"} [citrulline-p30642738] Effect of oral citrulline supplementation on whole body protein metabolism in adult patients with short bowel syndrome: A pilot, randomized, double-blind, cross-over study. (2019). https://pubmed.ncbi.nlm.nih.gov/30642738/ DOI: 10.1016/j.clnu.2018.12.030
Complete structured claim and evidenceWhole-body synthesis estimated by nonoxidative leucine disposal did not significantly change in the overall SBS group.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/30642738.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0d8869660890cdf77bcc2056b8871bc7be2b4828791a4681c87657a8efe42737", "start_char": 0, "end_char": 2343, "text_sha256": "0d8869660890cdf77bcc2056b8871bc7be2b4828791a4681c87657a8efe42737"}
- experimental_model
- Double-blind crossover isotope study
- exposure
- 0.18 g/kg/day citrulline for seven days versus isonitrogenous placebo
- limitations
- Near-normal nutritional status long after surgery; exploratory low-baseline subgroups were too small for a treatment rule.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, nine adults with stable nonmalignant short-bowel syndrome
- plain_language
- Higher exposure did not establish an overall anabolic benefit.
- primary_references
- [citrulline-p30642738] Effect of oral citrulline supplementation on whole body protein metabolism in adult patients with short bowel syndrome: A pilot, randomized, double-blind, cross-over study. (2019). https://pubmed.ncbi.nlm.nih.gov/30642738/ DOI: 10.1016/j.clnu.2018.12.030
- tissue_or_cell_type
- Whole-body protein metabolism
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1100–1111
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind crossover isotope study · source_derived_draft · unverified_draft
### citrulline-sbs-protein-null Whole-body synthesis estimated by nonoxidative leucine disposal did not significantly change in the overall SBS group. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Higher exposure did not establish an overall anabolic benefit. organism: Human, nine adults with stable nonmalignant short-bowel syndrome tissue_or_cell_type: Whole-body protein metabolism experimental_model: Double-blind crossover isotope study limitations: Near-normal nutritional status long after surgery; exploratory low-baseline subgroups were too small for a treatment rule. exposure: 0.18 g/kg/day citrulline for seven days versus isonitrogenous placebo evidence_span: {"source_cache": "artifacts/citrulline-research/30642738.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0d8869660890cdf77bcc2056b8871bc7be2b4828791a4681c87657a8efe42737", "start_char": 0, "end_char": 2343, "text_sha256": "0d8869660890cdf77bcc2056b8871bc7be2b4828791a4681c87657a8efe42737"} [citrulline-p30642738] Effect of oral citrulline supplementation on whole body protein metabolism in adult patients with short bowel syndrome: A pilot, randomized, double-blind, cross-over study. (2019). https://pubmed.ncbi.nlm.nih.gov/30642738/ DOI: 10.1016/j.clnu.2018.12.030
Complete structured claim and evidenceMean plasma citrulline was 20 ± 13 micromolar in short-bowel patients versus 40 ± 10 in controls.
Experimental context and source evidence
- availability_state
- biomarker_context Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/citrulline-research/11113071.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e2470fc206e5913038da9bb8d7a38677533224bd369ccd02563cefe760727246", "start_char": 0, "end_char": 2196, "text_sha256": "e2470fc206e5913038da9bb8d7a38677533224bd369ccd02563cefe760727246"}
- experimental_model
- Observational diagnostic study after intestinal adaptation
- exposure
- At least two years after final bowel reconstruction
- limitations
- The 20 micromolar classifier belongs to this cohort and indication, not a universal dietary deficiency cutoff.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 57 adults with short-bowel syndrome and 51 controls
- plain_language
- A low value can mark reduced intestinal production rather than low dietary intake.
- primary_references
- [citrulline-p11113071] Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. (2000). https://pubmed.ncbi.nlm.nih.gov/11113071/ DOI: 10.1053/gast.2000.20227
- tissue_or_cell_type
- Postabsorptive blood and intestinal absorptive function
- trigger_kind
- biomarker_context Imported condition classification; unverified.
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 970–981
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Observational diagnostic study after intestinal adaptation · source_derived_draft · unverified_draft
### citrulline-short-bowel-low Mean plasma citrulline was 20 ± 13 micromolar in short-bowel patients versus 40 ± 10 in controls. Condition category: biomarker_context nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: A low value can mark reduced intestinal production rather than low dietary intake. organism: Human, 57 adults with short-bowel syndrome and 51 controls tissue_or_cell_type: Postabsorptive blood and intestinal absorptive function experimental_model: Observational diagnostic study after intestinal adaptation limitations: The 20 micromolar classifier belongs to this cohort and indication, not a universal dietary deficiency cutoff. exposure: At least two years after final bowel reconstruction evidence_span: {"source_cache": "artifacts/citrulline-research/11113071.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e2470fc206e5913038da9bb8d7a38677533224bd369ccd02563cefe760727246", "start_char": 0, "end_char": 2196, "text_sha256": "e2470fc206e5913038da9bb8d7a38677533224bd369ccd02563cefe760727246"} [citrulline-p11113071] Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. (2000). https://pubmed.ncbi.nlm.nih.gov/11113071/ DOI: 10.1053/gast.2000.20227
Complete structured claim and evidenceThe highest citrulline regimen increased urinary cGMP from 38 to 50 nmol/mmol creatinine.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/17662090.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b", "start_char": 0, "end_char": 1980, "text_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b"}
- experimental_model
- Double-blind placebo-controlled crossover study
- exposure
- Citrulline 0.75, 1.5 or 3 g twice daily versus arginine formulations; one-week periods
- limitations
- Small short trial; NO-related urine markers do not establish a clinically meaningful vascular benefit.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 20 healthy volunteers
- plain_language
- A downstream signaling marker increased.
- primary_references
- [citrulline-p17662090] Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. (2008). https://pubmed.ncbi.nlm.nih.gov/17662090/ DOI: 10.1111/j.1365-2125.2007.02990.x
- tissue_or_cell_type
- Plasma amino acids, urine NO markers and brachial FMD
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 892–903
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind placebo-controlled crossover study · source_derived_draft · unverified_draft
### citrulline-urine-cgmp The highest citrulline regimen increased urinary cGMP from 38 to 50 nmol/mmol creatinine. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: A downstream signaling marker increased. organism: Human, 20 healthy volunteers tissue_or_cell_type: Plasma amino acids, urine NO markers and brachial FMD experimental_model: Double-blind placebo-controlled crossover study limitations: Small short trial; NO-related urine markers do not establish a clinically meaningful vascular benefit. exposure: Citrulline 0.75, 1.5 or 3 g twice daily versus arginine formulations; one-week periods evidence_span: {"source_cache": "artifacts/citrulline-research/17662090.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b", "start_char": 0, "end_char": 1980, "text_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b"} [citrulline-p17662090] Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. (2008). https://pubmed.ncbi.nlm.nih.gov/17662090/ DOI: 10.1111/j.1365-2125.2007.02990.x
Complete structured claim and evidenceThe highest regimen increased urinary nitrate from 92 to 125 micromol/mmol creatinine.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/17662090.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b", "start_char": 0, "end_char": 1980, "text_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b"}
- experimental_model
- Double-blind placebo-controlled crossover study
- exposure
- Citrulline 0.75, 1.5 or 3 g twice daily versus arginine formulations; one-week periods
- limitations
- Small short trial; NO-related urine markers do not establish a clinically meaningful vascular benefit.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 20 healthy volunteers
- plain_language
- Another NO-related marker changed.
- primary_references
- [citrulline-p17662090] Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. (2008). https://pubmed.ncbi.nlm.nih.gov/17662090/ DOI: 10.1111/j.1365-2125.2007.02990.x
- tissue_or_cell_type
- Plasma amino acids, urine NO markers and brachial FMD
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 905–916
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind placebo-controlled crossover study · source_derived_draft · unverified_draft
### citrulline-urine-nitrate The highest regimen increased urinary nitrate from 92 to 125 micromol/mmol creatinine. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Another NO-related marker changed. organism: Human, 20 healthy volunteers tissue_or_cell_type: Plasma amino acids, urine NO markers and brachial FMD experimental_model: Double-blind placebo-controlled crossover study limitations: Small short trial; NO-related urine markers do not establish a clinically meaningful vascular benefit. exposure: Citrulline 0.75, 1.5 or 3 g twice daily versus arginine formulations; one-week periods evidence_span: {"source_cache": "artifacts/citrulline-research/17662090.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b", "start_char": 0, "end_char": 1980, "text_sha256": "32e6ddf6d263120576f0f73c7fe3dd104904f3c0ba0a1c3f69cdca5751c4fa3b"} [citrulline-p17662090] Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. (2008). https://pubmed.ncbi.nlm.nih.gov/17662090/ DOI: 10.1111/j.1365-2125.2007.02990.x
Complete structured claim and evidenceLess than 5% of administered citrulline was excreted in urine, even at the higher tested doses.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/17953788.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b57ecb5b3484e857904f38ae7c5d5eea51177e2e0a9a9c15ba5f81c2200a11bd", "start_char": 0, "end_char": 1603, "text_sha256": "b57ecb5b3484e857904f38ae7c5d5eea51177e2e0a9a9c15ba5f81c2200a11bd"}
- experimental_model
- Randomized-order oral dose-loading study
- exposure
- Separate 2, 5, 10 and 15 g citrulline loads
- limitations
- Small acute tolerance study; saturation was an interpretation, not directly localized or measured renal enzyme saturation.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, eight healthy fasting men
- plain_language
- Most of the dose was not simply lost unchanged in urine.
- primary_references
- [citrulline-p17953788] Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study. (2008). https://pubmed.ncbi.nlm.nih.gov/17953788/ DOI: 10.1017/s0007114507841110
- tissue_or_cell_type
- Plasma amino acids and 24-hour urine
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 944–955
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized-order oral dose-loading study · source_derived_draft · unverified_draft
### citrulline-urine-retention Less than 5% of administered citrulline was excreted in urine, even at the higher tested doses. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Most of the dose was not simply lost unchanged in urine. organism: Human, eight healthy fasting men tissue_or_cell_type: Plasma amino acids and 24-hour urine experimental_model: Randomized-order oral dose-loading study limitations: Small acute tolerance study; saturation was an interpretation, not directly localized or measured renal enzyme saturation. exposure: Separate 2, 5, 10 and 15 g citrulline loads evidence_span: {"source_cache": "artifacts/citrulline-research/17953788.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b57ecb5b3484e857904f38ae7c5d5eea51177e2e0a9a9c15ba5f81c2200a11bd", "start_char": 0, "end_char": 1603, "text_sha256": "b57ecb5b3484e857904f38ae7c5d5eea51177e2e0a9a9c15ba5f81c2200a11bd"} [citrulline-p17953788] Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study. (2008). https://pubmed.ncbi.nlm.nih.gov/17953788/ DOI: 10.1017/s0007114507841110
Complete structured claim and evidence
What acts on it
In glutamine-supplemented surgical patients, 91% of total citrulline turnover was attributed to glutamine.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/25332337.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d517656dd9033a9df73e29b10d07fdccbc7c369155450ba662fe006d045cf4d0", "start_char": 0, "end_char": 1788, "text_sha256": "d517656dd9033a9df73e29b10d07fdccbc7c369155450ba662fe006d045cf4d0"}
- experimental_model
- Stable-isotope whole-body and renal balance study
- exposure
- Perioperative intravenous alanyl-glutamine 0.5 g/kg/day
- limitations
- Small perioperative study; the reported doubling versus previous studies was not a concurrent randomized control comparison.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, seven surgical patients
- plain_language
- Glutamine supplied much of the precursor carbon in this experimental setting.
- primary_references
- [citrulline-p25332337] Intravenous glutamine supplementation enhances renal de novo arginine synthesis in humans: a stable isotope study. (2014). https://pubmed.ncbi.nlm.nih.gov/25332337/ DOI: 10.3945/ajcn.113.081547
- tissue_or_cell_type
- Intestinal-renal amino-acid axis
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 437–448
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Stable-isotope whole-body and renal balance study · source_derived_draft · unverified_draft
### citrulline-glutamine-source In glutamine-supplemented surgical patients, 91% of total citrulline turnover was attributed to glutamine. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Glutamine supplied much of the precursor carbon in this experimental setting. organism: Human, seven surgical patients tissue_or_cell_type: Intestinal-renal amino-acid axis experimental_model: Stable-isotope whole-body and renal balance study limitations: Small perioperative study; the reported doubling versus previous studies was not a concurrent randomized control comparison. exposure: Perioperative intravenous alanyl-glutamine 0.5 g/kg/day evidence_span: {"source_cache": "artifacts/citrulline-research/25332337.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d517656dd9033a9df73e29b10d07fdccbc7c369155450ba662fe006d045cf4d0", "start_char": 0, "end_char": 1788, "text_sha256": "d517656dd9033a9df73e29b10d07fdccbc7c369155450ba662fe006d045cf4d0"} [citrulline-p25332337] Intravenous glutamine supplementation enhances renal de novo arginine synthesis in humans: a stable isotope study. (2014). https://pubmed.ncbi.nlm.nih.gov/25332337/ DOI: 10.3945/ajcn.113.081547
Complete structured claim and evidencePurified human eNOS converted arginine in an assay measuring citrulline formation, with an arginine Km of 3.9 micromolar.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/10608822.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1600b193cc63f30b204285729710bb81f34bc2918a8ca7f97aa97bc4acd998fd", "start_char": 0, "end_char": 2100, "text_sha256": "1600b193cc63f30b204285729710bb81f34bc2918a8ca7f97aa97bc4acd998fd"}
- experimental_model
- Purified recombinant enzyme activity and cofactor analysis
- exposure
- Arginine substrate; BH4, FAD, FMN, heme, iron and zinc measurements
- limitations
- Biochemical cofactor findings do not show that extra dietary cofactors increase NO in healthy people.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human NOS3 expressed in yeast
- plain_language
- Citrulline is also produced when the nitric-oxide pathway uses arginine.
- primary_references
- [citrulline-p10608822] Characterization of recombinant human endothelial nitric-oxide synthase purified from the yeast Pichia pastoris. (1999). https://pubmed.ncbi.nlm.nih.gov/10608822/ DOI: 10.1074/jbc.274.53.37658
- tissue_or_cell_type
- Endothelial NOS enzyme preparation
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 502–513
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified recombinant enzyme activity and cofactor analysis · source_derived_draft · unverified_draft
### citrulline-nos-citrulline Purified human eNOS converted arginine in an assay measuring citrulline formation, with an arginine Km of 3.9 micromolar. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Citrulline is also produced when the nitric-oxide pathway uses arginine. organism: Human NOS3 expressed in yeast tissue_or_cell_type: Endothelial NOS enzyme preparation experimental_model: Purified recombinant enzyme activity and cofactor analysis limitations: Biochemical cofactor findings do not show that extra dietary cofactors increase NO in healthy people. exposure: Arginine substrate; BH4, FAD, FMN, heme, iron and zinc measurements evidence_span: {"source_cache": "artifacts/citrulline-research/10608822.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1600b193cc63f30b204285729710bb81f34bc2918a8ca7f97aa97bc4acd998fd", "start_char": 0, "end_char": 2100, "text_sha256": "1600b193cc63f30b204285729710bb81f34bc2918a8ca7f97aa97bc4acd998fd"} [citrulline-p10608822] Characterization of recombinant human endothelial nitric-oxide synthase purified from the yeast Pichia pastoris. (1999). https://pubmed.ncbi.nlm.nih.gov/10608822/ DOI: 10.1074/jbc.274.53.37658
Complete structured claim and evidenceHuman OTC converts ornithine and carbamoyl phosphate into citrulline, releasing inorganic phosphate.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/38940639.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5eca9d57812cf3d8efe7c0beb62b9b364cc25e1aeca647c95e4abf0fd9eb8365", "start_char": 194, "end_char": 364, "text_sha256": "c5ddbcd5c91cfcdc72d6e556c77228f8ecd6c25ebaa3c25fd9617f6baa145692"}
- experimental_model
- Recombinant enzyme site-directed mutagenesis and kinetic assays
- exposure
- Ornithine and carbamoyl phosphate; active-site and remote variants
- limitations
- Recombinant mutation experiments; do not equate altered enzyme function with a dietary shortage.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human OTC
- plain_language
- Citrulline is built from ornithine and a nitrogen-containing carbamoyl group.
- primary_references
- [citrulline-p38940639] Revisiting the Roles of Catalytic Residues in Human Ornithine Transcarbamylase. (2024). https://pubmed.ncbi.nlm.nih.gov/38940639/ DOI: 10.1021/acs.biochem.4c00206
- tissue_or_cell_type
- Mitochondrial urea-cycle enzyme
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 203–214
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant enzyme site-directed mutagenesis and kinetic assays · source_derived_draft · unverified_draft
### citrulline-otc-citrulline Human OTC converts ornithine and carbamoyl phosphate into citrulline, releasing inorganic phosphate. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Citrulline is built from ornithine and a nitrogen-containing carbamoyl group. organism: Human OTC tissue_or_cell_type: Mitochondrial urea-cycle enzyme experimental_model: Recombinant enzyme site-directed mutagenesis and kinetic assays limitations: Recombinant mutation experiments; do not equate altered enzyme function with a dietary shortage. exposure: Ornithine and carbamoyl phosphate; active-site and remote variants evidence_span: {"source_cache": "artifacts/citrulline-research/38940639.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5eca9d57812cf3d8efe7c0beb62b9b364cc25e1aeca647c95e4abf0fd9eb8365", "start_char": 194, "end_char": 364, "text_sha256": "c5ddbcd5c91cfcdc72d6e556c77228f8ecd6c25ebaa3c25fd9617f6baa145692"} [citrulline-p38940639] Revisiting the Roles of Catalytic Residues in Human Ornithine Transcarbamylase. (2024). https://pubmed.ncbi.nlm.nih.gov/38940639/ DOI: 10.1021/acs.biochem.4c00206
Complete structured claim and evidence
Where it participates (unsigned role)
Agmatine competitively inhibited the brain-derived NOS I preparation with approximate Ki 660 micromolar and was not an NO precursor.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- NOS activity measured by nitrite or citrulline production; species not specified in accessed abstract.
- limitations
- Isolated-preparation potency does not quantify inhibition after an oral sulfate dose.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- An arginine-related compound can inhibit the enzyme rather than supply its product.
- primary_references
- Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. · 1996 · https://pubmed.ncbi.nlm.nih.gov/8645212/ · DOI 10.1042/bj3160247
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 220–226
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · NOS activity measured by nitrite or citrulline production; species not specified in accessed abstract. · source_derived_draft · unverified_draft
## agmatine-sulfate-nos1-inhibition An arginine-related compound can inhibit the enzyme rather than supply its product. Agmatine competitively inhibited the brain-derived NOS I preparation with approximate Ki 660 micromolar and was not an NO precursor. Model: NOS activity measured by nitrite or citrulline production; species not specified in accessed abstract. Limitations: Isolated-preparation potency does not quantify inhibition after an oral sulfate dose. Evidence access: Primary abstract Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. · 1996 · https://pubmed.ncbi.nlm.nih.gov/8645212/ · DOI 10.1042/bj3160247
Complete structured claim and evidenceAgmatine competitively inhibited macrophage-derived NOS II with approximate Ki 220 micromolar.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Macrophage NOS preparation; enzymatic activity assay.
- limitations
- This is not a universal inflammatory-cell response or a human concentration target.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- NOS isoforms showed different assay sensitivities.
- primary_references
- Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. · 1996 · https://pubmed.ncbi.nlm.nih.gov/8645212/ · DOI 10.1042/bj3160247
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 228–234
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Macrophage NOS preparation; enzymatic activity assay. · source_derived_draft · unverified_draft
## agmatine-sulfate-nos2-inhibition NOS isoforms showed different assay sensitivities. Agmatine competitively inhibited macrophage-derived NOS II with approximate Ki 220 micromolar. Model: Macrophage NOS preparation; enzymatic activity assay. Limitations: This is not a universal inflammatory-cell response or a human concentration target. Evidence access: Primary abstract Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. · 1996 · https://pubmed.ncbi.nlm.nih.gov/8645212/ · DOI 10.1042/bj3160247
Complete structured claim and evidenceAspartate is a substrate of human ASS1 and was resolved with citrulline in the enzyme structure.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/18323623.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "079be80a0ea1a47308efb069d3c9522c96c0aa5923ad1d7ce79ac620b2d9502f", "start_char": 0, "end_char": 840, "text_sha256": "079be80a0ea1a47308efb069d3c9522c96c0aa5923ad1d7ce79ac620b2d9502f"}
- experimental_model
- Crystal structure and biochemical reaction characterization
- exposure
- Citrulline and aspartate bound to recombinant enzyme
- limitations
- Structure and established reaction; no clinical magnesium, aspartate or ATP deficiency threshold is established.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human ASS1
- plain_language
- Aspartate supplies part of the molecule built at this step.
- primary_references
- [citrulline-p18323623] Structure of human argininosuccinate synthetase. (2008). https://pubmed.ncbi.nlm.nih.gov/18323623/ DOI: 10.1107/s0907444907067455
- tissue_or_cell_type
- Cytosolic arginine-regeneration reaction
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 138–149
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Crystal structure and biochemical reaction characterization · source_derived_draft · unverified_draft
### citrulline-ass1-aspartate Aspartate is a substrate of human ASS1 and was resolved with citrulline in the enzyme structure. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Aspartate supplies part of the molecule built at this step. organism: Human ASS1 tissue_or_cell_type: Cytosolic arginine-regeneration reaction experimental_model: Crystal structure and biochemical reaction characterization limitations: Structure and established reaction; no clinical magnesium, aspartate or ATP deficiency threshold is established. exposure: Citrulline and aspartate bound to recombinant enzyme evidence_span: {"source_cache": "artifacts/citrulline-research/18323623.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "079be80a0ea1a47308efb069d3c9522c96c0aa5923ad1d7ce79ac620b2d9502f", "start_char": 0, "end_char": 840, "text_sha256": "079be80a0ea1a47308efb069d3c9522c96c0aa5923ad1d7ce79ac620b2d9502f"} [citrulline-p18323623] Structure of human argininosuccinate synthetase. (2008). https://pubmed.ncbi.nlm.nih.gov/18323623/ DOI: 10.1107/s0907444907067455
Complete structured claim and evidenceThe ASS1 reaction uses ATP cleavage to AMP and pyrophosphate.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/18323623.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "079be80a0ea1a47308efb069d3c9522c96c0aa5923ad1d7ce79ac620b2d9502f", "start_char": 0, "end_char": 840, "text_sha256": "079be80a0ea1a47308efb069d3c9522c96c0aa5923ad1d7ce79ac620b2d9502f"}
- experimental_model
- Crystal structure and biochemical reaction characterization
- exposure
- Citrulline and aspartate bound to recombinant enzyme
- limitations
- Structure and established reaction; no clinical magnesium, aspartate or ATP deficiency threshold is established.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human ASS1
- plain_language
- Arginine regeneration has an energy cost.
- primary_references
- [citrulline-p18323623] Structure of human argininosuccinate synthetase. (2008). https://pubmed.ncbi.nlm.nih.gov/18323623/ DOI: 10.1107/s0907444907067455
- tissue_or_cell_type
- Cytosolic arginine-regeneration reaction
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 151–162
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Crystal structure and biochemical reaction characterization · source_derived_draft · unverified_draft
### citrulline-ass1-energy The ASS1 reaction uses ATP cleavage to AMP and pyrophosphate. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Arginine regeneration has an energy cost. organism: Human ASS1 tissue_or_cell_type: Cytosolic arginine-regeneration reaction experimental_model: Crystal structure and biochemical reaction characterization limitations: Structure and established reaction; no clinical magnesium, aspartate or ATP deficiency threshold is established. exposure: Citrulline and aspartate bound to recombinant enzyme evidence_span: {"source_cache": "artifacts/citrulline-research/18323623.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "079be80a0ea1a47308efb069d3c9522c96c0aa5923ad1d7ce79ac620b2d9502f", "start_char": 0, "end_char": 840, "text_sha256": "079be80a0ea1a47308efb069d3c9522c96c0aa5923ad1d7ce79ac620b2d9502f"} [citrulline-p18323623] Structure of human argininosuccinate synthetase. (2008). https://pubmed.ncbi.nlm.nih.gov/18323623/ DOI: 10.1107/s0907444907067455
Complete structured claim and evidenceASS1 knockdown reduced basal and stimulated NO despite saturating arginine in the culture medium.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/citrulline-research/14970240.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7d7acfd232edfd5d968d7afcbaf80ea27807a4313b5a385c90fd11b437403056", "start_char": 0, "end_char": 1589, "text_sha256": "7d7acfd232edfd5d968d7afcbaf80ea27807a4313b5a385c90fd11b437403056"}
- experimental_model
- RNA-interference and NO-donor rescue experiments
- exposure
- ASS1 knockdown despite saturating extracellular arginine
- limitations
- Bovine cell model; no claim that every human tissue exclusively uses regenerated arginine.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Bovine aortic endothelial cells
- plain_language
- Bulk substrate abundance did not compensate for impaired local recycling.
- primary_references
- [citrulline-p14970240] Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells. (2004). https://pubmed.ncbi.nlm.nih.gov/14970240/ DOI: 10.1074/jbc.m308160200
- tissue_or_cell_type
- Citrulline recycling, NO synthesis and viability
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 658–669
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · RNA-interference and NO-donor rescue experiments · source_derived_draft · unverified_draft
### citrulline-ass1-local-no ASS1 knockdown reduced basal and stimulated NO despite saturating arginine in the culture medium. Condition category: machinery_impairment nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Bulk substrate abundance did not compensate for impaired local recycling. organism: Bovine aortic endothelial cells tissue_or_cell_type: Citrulline recycling, NO synthesis and viability experimental_model: RNA-interference and NO-donor rescue experiments limitations: Bovine cell model; no claim that every human tissue exclusively uses regenerated arginine. exposure: ASS1 knockdown despite saturating extracellular arginine evidence_span: {"source_cache": "artifacts/citrulline-research/14970240.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7d7acfd232edfd5d968d7afcbaf80ea27807a4313b5a385c90fd11b437403056", "start_char": 0, "end_char": 1589, "text_sha256": "7d7acfd232edfd5d968d7afcbaf80ea27807a4313b5a385c90fd11b437403056"} [citrulline-p14970240] Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells. (2004). https://pubmed.ncbi.nlm.nih.gov/14970240/ DOI: 10.1074/jbc.m308160200
Complete structured claim and evidenceHuman ASS1 combines citrulline and aspartate to form argininosuccinate in an ATP-dependent reaction.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/18323623.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "079be80a0ea1a47308efb069d3c9522c96c0aa5923ad1d7ce79ac620b2d9502f", "start_char": 0, "end_char": 840, "text_sha256": "079be80a0ea1a47308efb069d3c9522c96c0aa5923ad1d7ce79ac620b2d9502f"}
- experimental_model
- Crystal structure and biochemical reaction characterization
- exposure
- Citrulline and aspartate bound to recombinant enzyme
- limitations
- Structure and established reaction; no clinical magnesium, aspartate or ATP deficiency threshold is established.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human ASS1
- plain_language
- Citrulline needs a second amino acid and an enzyme-controlled step before it becomes arginine.
- primary_references
- [citrulline-p18323623] Structure of human argininosuccinate synthetase. (2008). https://pubmed.ncbi.nlm.nih.gov/18323623/ DOI: 10.1107/s0907444907067455
- tissue_or_cell_type
- Cytosolic arginine-regeneration reaction
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 125–136
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Crystal structure and biochemical reaction characterization · source_derived_draft · unverified_draft
### citrulline-ass1-reaction Human ASS1 combines citrulline and aspartate to form argininosuccinate in an ATP-dependent reaction. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Citrulline needs a second amino acid and an enzyme-controlled step before it becomes arginine. organism: Human ASS1 tissue_or_cell_type: Cytosolic arginine-regeneration reaction experimental_model: Crystal structure and biochemical reaction characterization limitations: Structure and established reaction; no clinical magnesium, aspartate or ATP deficiency threshold is established. exposure: Citrulline and aspartate bound to recombinant enzyme evidence_span: {"source_cache": "artifacts/citrulline-research/18323623.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "079be80a0ea1a47308efb069d3c9522c96c0aa5923ad1d7ce79ac620b2d9502f", "start_char": 0, "end_char": 840, "text_sha256": "079be80a0ea1a47308efb069d3c9522c96c0aa5923ad1d7ce79ac620b2d9502f"} [citrulline-p18323623] Structure of human argininosuccinate synthetase. (2008). https://pubmed.ncbi.nlm.nih.gov/18323623/ DOI: 10.1107/s0907444907067455
Complete structured claim and evidenceRepetitions did not improve with CM: 90.9 versus 94.0 on placebo, P=0.33.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/30097067.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8f08d4e244a48b116a8a2a734514e0cf13d3953bcae33722f996121bab8efbb2", "start_char": 0, "end_char": 1678, "text_sha256": "8f08d4e244a48b116a8a2a734514e0cf13d3953bcae33722f996121bab8efbb2"}
- experimental_model
- Randomized double-blind counterbalanced exercise study and product analysis
- exposure
- 8 g CM with measured citrulline:malate ratio 1.11:1
- limitations
- Exercise, participant mix and product composition differed from the 2010 study; the cause of discrepant soreness is unproven.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human recreationally active men and women
- plain_language
- This protocol did not reproduce a performance gain.
- primary_references
- [citrulline-p30097067] Citrulline malate supplementation does not improve German Volume Training performance or reduce muscle soreness in moderately trained males and females. (2018). https://pubmed.ncbi.nlm.nih.gov/30097067/ DOI: 10.1186/s12970-018-0245-8
- tissue_or_cell_type
- Isokinetic German Volume Training and 72-hour soreness
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1152–1163
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind counterbalanced exercise study and product analysis · source_derived_draft · unverified_draft
### citrulline-exercise-null Repetitions did not improve with CM: 90.9 versus 94.0 on placebo, P=0.33. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: This protocol did not reproduce a performance gain. organism: Human recreationally active men and women tissue_or_cell_type: Isokinetic German Volume Training and 72-hour soreness experimental_model: Randomized double-blind counterbalanced exercise study and product analysis limitations: Exercise, participant mix and product composition differed from the 2010 study; the cause of discrepant soreness is unproven. exposure: 8 g CM with measured citrulline:malate ratio 1.11:1 evidence_span: {"source_cache": "artifacts/citrulline-research/30097067.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8f08d4e244a48b116a8a2a734514e0cf13d3953bcae33722f996121bab8efbb2", "start_char": 0, "end_char": 1678, "text_sha256": "8f08d4e244a48b116a8a2a734514e0cf13d3953bcae33722f996121bab8efbb2"} [citrulline-p30097067] Citrulline malate supplementation does not improve German Volume Training performance or reduce muscle soreness in moderately trained males and females. (2018). https://pubmed.ncbi.nlm.nih.gov/30097067/ DOI: 10.1186/s12970-018-0245-8
Complete structured claim and evidenceCM increased repetitions in later bench-press sets; the reported final-set relative gain was 52.92%.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/20386132.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a095891368caeebaa857f5dcf2651e1498924f2006969255d252c1d8caa91847", "start_char": 0, "end_char": 1637, "text_sha256": "a095891368caeebaa857f5dcf2651e1498924f2006969255d252c1d8caa91847"}
- experimental_model
- Randomized double-blind crossover exercise trial
- exposure
- 8 g citrulline malate before a high-volume pectoral session
- limitations
- CM is not pure L-citrulline; last-set relative change is not a whole-workout gain; perceived soreness is subjective.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 41 men
- plain_language
- This result belongs to a demanding repeated-set protocol.
- primary_references
- [citrulline-p20386132] Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness. (2010). https://pubmed.ncbi.nlm.nih.gov/20386132/ DOI: 10.1519/jsc.0b013e3181cb28e0
- tissue_or_cell_type
- Bench-press repetitions and self-reported soreness
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1113–1124
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind crossover exercise trial · source_derived_draft · unverified_draft
### citrulline-exercise-positive CM increased repetitions in later bench-press sets; the reported final-set relative gain was 52.92%. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: This result belongs to a demanding repeated-set protocol. organism: Human, 41 men tissue_or_cell_type: Bench-press repetitions and self-reported soreness experimental_model: Randomized double-blind crossover exercise trial limitations: CM is not pure L-citrulline; last-set relative change is not a whole-workout gain; perceived soreness is subjective. exposure: 8 g citrulline malate before a high-volume pectoral session evidence_span: {"source_cache": "artifacts/citrulline-research/20386132.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a095891368caeebaa857f5dcf2651e1498924f2006969255d252c1d8caa91847", "start_char": 0, "end_char": 1637, "text_sha256": "a095891368caeebaa857f5dcf2651e1498924f2006969255d252c1d8caa91847"} [citrulline-p20386132] Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness. (2010). https://pubmed.ncbi.nlm.nih.gov/20386132/ DOI: 10.1519/jsc.0b013e3181cb28e0
Complete structured claim and evidenceNeither pure citrulline nor matched-citrulline-dose CM improved repetitions or other strength-endurance measures.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/39662304.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3f26c60b31d2021fb82143a4780ab4437e58c18d1c482a0880fdc4321f224092", "start_char": 0, "end_char": 1816, "text_sha256": "3f26c60b31d2021fb82143a4780ab4437e58c18d1c482a0880fdc4321f224092"}
- experimental_model
- Randomized double-blind placebo-controlled crossover trial
- exposure
- 5.3 g L-citrulline; or 5.3 g citrulline plus 2.7 g malate; or placebo 45 minutes pre-exercise
- limitations
- Acute low-to-moderate-volume protocol; not a universal finding for all doses, workouts or chronic use.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 43 trained adults including 21 women
- plain_language
- Adding malate did not demonstrate an extra benefit in this trial.
- primary_references
- [citrulline-p39662304] Malate or Not? Acute Effects of L-Citrulline Versus Citrulline Malate on Neuromuscular Performance in Young, Trained Adults: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial. (2025). https://pubmed.ncbi.nlm.nih.gov/39662304/ DOI: 10.1123/ijsnem.2024-0006
- tissue_or_cell_type
- Neuromuscular, ballistic and strength-endurance tests
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1191–1202
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind placebo-controlled crossover trial · source_derived_draft · unverified_draft
### citrulline-matched-malate-null Neither pure citrulline nor matched-citrulline-dose CM improved repetitions or other strength-endurance measures. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Adding malate did not demonstrate an extra benefit in this trial. organism: Human, 43 trained adults including 21 women tissue_or_cell_type: Neuromuscular, ballistic and strength-endurance tests experimental_model: Randomized double-blind placebo-controlled crossover trial limitations: Acute low-to-moderate-volume protocol; not a universal finding for all doses, workouts or chronic use. exposure: 5.3 g L-citrulline; or 5.3 g citrulline plus 2.7 g malate; or placebo 45 minutes pre-exercise evidence_span: {"source_cache": "artifacts/citrulline-research/39662304.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3f26c60b31d2021fb82143a4780ab4437e58c18d1c482a0880fdc4321f224092", "start_char": 0, "end_char": 1816, "text_sha256": "3f26c60b31d2021fb82143a4780ab4437e58c18d1c482a0880fdc4321f224092"} [citrulline-p39662304] Malate or Not? Acute Effects of L-Citrulline Versus Citrulline Malate on Neuromuscular Performance in Young, Trained Adults: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial. (2025). https://pubmed.ncbi.nlm.nih.gov/39662304/ DOI: 10.1123/ijsnem.2024-0006
Complete structured claim and evidenceCells expressing human endothelial NOS produced bioactive NO that increased guanylate cyclase activity in cocultured reporter cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/1378832.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "265be186f6d8172b272e7b1e75b4fbae12a6df78c7396cad499bce2b195b1206", "start_char": 0, "end_char": 1652, "text_sha256": "265be186f6d8172b272e7b1e75b4fbae12a6df78c7396cad499bce2b195b1206"}
- experimental_model
- Functional expression and reporter-cell coculture
- exposure
- NOS3 transfection and calcium ionophore A23187
- limitations
- Heterologous expression; reporter activation supports bioactive NO production, not a clinical calcium supplementation effect.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human NOS3 expressed in NIH3T3 cells; rat reporter fibroblasts
- plain_language
- Arginine feeds an enzyme that makes the signal NO while also producing citrulline.
- primary_references
- [citrulline-p1378832] Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. (1992). https://pubmed.ncbi.nlm.nih.gov/1378832/ DOI: 10.1016/s0021-9258(18)42066-2
- tissue_or_cell_type
- Arginine conversion and NO-dependent reporter guanylate cyclase activity
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 463–474
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Functional expression and reporter-cell coculture · source_derived_draft · unverified_draft
### citrulline-nos-no Cells expressing human endothelial NOS produced bioactive NO that increased guanylate cyclase activity in cocultured reporter cells. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Arginine feeds an enzyme that makes the signal NO while also producing citrulline. organism: Human NOS3 expressed in NIH3T3 cells; rat reporter fibroblasts tissue_or_cell_type: Arginine conversion and NO-dependent reporter guanylate cyclase activity experimental_model: Functional expression and reporter-cell coculture limitations: Heterologous expression; reporter activation supports bioactive NO production, not a clinical calcium supplementation effect. exposure: NOS3 transfection and calcium ionophore A23187 evidence_span: {"source_cache": "artifacts/citrulline-research/1378832.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "265be186f6d8172b272e7b1e75b4fbae12a6df78c7396cad499bce2b195b1206", "start_char": 0, "end_char": 1652, "text_sha256": "265be186f6d8172b272e7b1e75b4fbae12a6df78c7396cad499bce2b195b1206"} [citrulline-p1378832] Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. (1992). https://pubmed.ncbi.nlm.nih.gov/1378832/ DOI: 10.1016/s0021-9258(18)42066-2
Complete structured claim and evidenceThe two R84Q siblings had hypocitrullinemia with low ornithine, arginine and proline; the variant strongly reduced expressed P5CS activity.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/citrulline-research/11092761.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "09706fd9ec135c472473decaa612e06b3e5aa021c9b1493d77daf4fe98b8d5d2", "start_char": 0, "end_char": 1688, "text_sha256": "09706fd9ec135c472473decaa612e06b3e5aa021c9b1493d77daf4fe98b8d5d2"}
- experimental_model
- Patient genetics and recombinant variant expression
- exposure
- ALDH18A1 R84Q compared with wild-type isoforms
- limitations
- Rare inherited enzyme disorder; does not imply low dietary citrulline caused the clinical phenotype.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, two siblings and mammalian expression systems
- plain_language
- Low citrulline can arise from a defective upstream enzyme.
- primary_references
- [citrulline-p11092761] Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase. (2000). https://pubmed.ncbi.nlm.nih.gov/11092761/ DOI: 10.1093/hmg/9.19.2853
- tissue_or_cell_type
- Mitochondrial P5CS and circulating amino acids
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 320–331
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Patient genetics and recombinant variant expression · source_derived_draft · unverified_draft
### citrulline-p5cs-low-citrulline The two R84Q siblings had hypocitrullinemia with low ornithine, arginine and proline; the variant strongly reduced expressed P5CS activity. Condition category: machinery_impairment nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Low citrulline can arise from a defective upstream enzyme. organism: Human, two siblings and mammalian expression systems tissue_or_cell_type: Mitochondrial P5CS and circulating amino acids experimental_model: Patient genetics and recombinant variant expression limitations: Rare inherited enzyme disorder; does not imply low dietary citrulline caused the clinical phenotype. exposure: ALDH18A1 R84Q compared with wild-type isoforms evidence_span: {"source_cache": "artifacts/citrulline-research/11092761.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "09706fd9ec135c472473decaa612e06b3e5aa021c9b1493d77daf4fe98b8d5d2", "start_char": 0, "end_char": 1688, "text_sha256": "09706fd9ec135c472473decaa612e06b3e5aa021c9b1493d77daf4fe98b8d5d2"} [citrulline-p11092761] Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase. (2000). https://pubmed.ncbi.nlm.nih.gov/11092761/ DOI: 10.1093/hmg/9.19.2853
Complete structured claim and evidenceAdding BH4 increased the reported walking-distance change to 28.15% only in the subgroup with baseline ADMA above 0.4 micromolar.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/39985883.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c", "start_char": 0, "end_char": 1888, "text_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c"}
- experimental_model
- Phase II double-blind placebo-controlled crossover trial
- exposure
- 3 g citrulline twice daily for 12 weeks; additional BH4 0.45 g/day for two weeks in one arm
- limitations
- Preliminary trial; subgroup-dependent BH4 result and study-specific ADMA cutoff require confirmation; not a general supplement prescription.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 51 peripheral-artery-disease patients
- plain_language
- The cofactor combination result depended on the measured starting state.
- primary_references
- [citrulline-p39985883] Nutritional L-Citrulline and Tetrahydrobiopterin in Peripheral Artery Disease: A Phase II Randomized Trial (CIPER Study). (2025). https://pubmed.ncbi.nlm.nih.gov/39985883/ DOI: 10.1016/j.jacadv.2025.101590
- tissue_or_cell_type
- Absolute claudication distance and plasma biomarkers
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1217–1228
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Phase II double-blind placebo-controlled crossover trial · source_derived_draft · unverified_draft
### citrulline-pad-bh4-subgroup Adding BH4 increased the reported walking-distance change to 28.15% only in the subgroup with baseline ADMA above 0.4 micromolar. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The cofactor combination result depended on the measured starting state. organism: Human, 51 peripheral-artery-disease patients tissue_or_cell_type: Absolute claudication distance and plasma biomarkers experimental_model: Phase II double-blind placebo-controlled crossover trial limitations: Preliminary trial; subgroup-dependent BH4 result and study-specific ADMA cutoff require confirmation; not a general supplement prescription. exposure: 3 g citrulline twice daily for 12 weeks; additional BH4 0.45 g/day for two weeks in one arm evidence_span: {"source_cache": "artifacts/citrulline-research/39985883.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c", "start_char": 0, "end_char": 1888, "text_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c"} [citrulline-p39985883] Nutritional L-Citrulline and Tetrahydrobiopterin in Peripheral Artery Disease: A Phase II Randomized Trial (CIPER Study). (2025). https://pubmed.ncbi.nlm.nih.gov/39985883/ DOI: 10.1016/j.jacadv.2025.101590
Complete structured claim and evidenceCombination treatment improved eNOS dimer ratios and NO production more than either single intervention.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/32073878.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f", "start_char": 0, "end_char": 1850, "text_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f"}
- experimental_model
- Controlled neonatal hypoxia and combination-treatment experiment
- exposure
- L-citrulline, sapropterin, or both during days 3-10 of hypoxia
- limitations
- Animal combination evidence; does not establish neonatal clinical dosing or treatment benefit in humans.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Newborn pig
- plain_language
- The measured signaling machinery responded alongside the vascular outcome.
- primary_references
- [citrulline-p32073878] Combined l-citrulline and tetrahydrobiopterin therapy improves NO signaling and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs. (2020). https://pubmed.ncbi.nlm.nih.gov/32073878/ DOI: 10.1152/ajplung.00280.2019
- tissue_or_cell_type
- Pulmonary arteries and hemodynamics
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 827–838
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Controlled neonatal hypoxia and combination-treatment experiment · source_derived_draft · unverified_draft
### citrulline-pig-combination-coupling Combination treatment improved eNOS dimer ratios and NO production more than either single intervention. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The measured signaling machinery responded alongside the vascular outcome. organism: Newborn pig tissue_or_cell_type: Pulmonary arteries and hemodynamics experimental_model: Controlled neonatal hypoxia and combination-treatment experiment limitations: Animal combination evidence; does not establish neonatal clinical dosing or treatment benefit in humans. exposure: L-citrulline, sapropterin, or both during days 3-10 of hypoxia evidence_span: {"source_cache": "artifacts/citrulline-research/32073878.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f", "start_char": 0, "end_char": 1850, "text_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f"} [citrulline-p32073878] Combined l-citrulline and tetrahydrobiopterin therapy improves NO signaling and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs. (2020). https://pubmed.ncbi.nlm.nih.gov/32073878/ DOI: 10.1152/ajplung.00280.2019
Complete structured claim and evidenceCombined citrulline and BH4 improved pulmonary vascular resistance more than either alone in hypoxic piglets.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/32073878.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f", "start_char": 0, "end_char": 1850, "text_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f"}
- experimental_model
- Controlled neonatal hypoxia and combination-treatment experiment
- exposure
- L-citrulline, sapropterin, or both during days 3-10 of hypoxia
- limitations
- Animal combination evidence; does not establish neonatal clinical dosing or treatment benefit in humans.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Newborn pig
- plain_language
- Both substrate supply and cofactor support mattered in this animal model.
- primary_references
- [citrulline-p32073878] Combined l-citrulline and tetrahydrobiopterin therapy improves NO signaling and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs. (2020). https://pubmed.ncbi.nlm.nih.gov/32073878/ DOI: 10.1152/ajplung.00280.2019
- tissue_or_cell_type
- Pulmonary arteries and hemodynamics
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 814–825
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Controlled neonatal hypoxia and combination-treatment experiment · source_derived_draft · unverified_draft
### citrulline-pig-combination-pvr Combined citrulline and BH4 improved pulmonary vascular resistance more than either alone in hypoxic piglets. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Both substrate supply and cofactor support mattered in this animal model. organism: Newborn pig tissue_or_cell_type: Pulmonary arteries and hemodynamics experimental_model: Controlled neonatal hypoxia and combination-treatment experiment limitations: Animal combination evidence; does not establish neonatal clinical dosing or treatment benefit in humans. exposure: L-citrulline, sapropterin, or both during days 3-10 of hypoxia evidence_span: {"source_cache": "artifacts/citrulline-research/32073878.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f", "start_char": 0, "end_char": 1850, "text_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f"} [citrulline-p32073878] Combined l-citrulline and tetrahydrobiopterin therapy improves NO signaling and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs. (2020). https://pubmed.ncbi.nlm.nih.gov/32073878/ DOI: 10.1152/ajplung.00280.2019
Complete structured claim and evidenceSilencing SLC6A19 reduced citrulline uptake in human HK-2 renal cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/19322909.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f466fcced77ee9fe7a97f010112a035332d513382d13e6187d10bc02be152ece", "start_char": 0, "end_char": 1531, "text_sha256": "f466fcced77ee9fe7a97f010112a035332d513382d13e6187d10bc02be152ece"}
- experimental_model
- Apical transport kinetics and transporter knockdown
- exposure
- Citrulline uptake on permeable supports; SLC6A19 or SLC7A9 silencing
- limitations
- Renal evidence must not be relabeled as a demonstrated human intestinal transport mechanism.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human HK-2 cells; rat cultures studied separately
- plain_language
- A neutral-amino-acid transporter contributes to kidney uptake.
- primary_references
- [citrulline-p19322909] Transport characteristics of L-citrulline in renal apical membrane of proximal tubular cells. (2009). https://pubmed.ncbi.nlm.nih.gov/19322909/ DOI: 10.1002/bdd.653
- tissue_or_cell_type
- Renal proximal tubular epithelium
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 398–409
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Apical transport kinetics and transporter knockdown · source_derived_draft · unverified_draft
### citrulline-renal-b0at1 Silencing SLC6A19 reduced citrulline uptake in human HK-2 renal cells. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: A neutral-amino-acid transporter contributes to kidney uptake. organism: Human HK-2 cells; rat cultures studied separately tissue_or_cell_type: Renal proximal tubular epithelium experimental_model: Apical transport kinetics and transporter knockdown limitations: Renal evidence must not be relabeled as a demonstrated human intestinal transport mechanism. exposure: Citrulline uptake on permeable supports; SLC6A19 or SLC7A9 silencing evidence_span: {"source_cache": "artifacts/citrulline-research/19322909.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f466fcced77ee9fe7a97f010112a035332d513382d13e6187d10bc02be152ece", "start_char": 0, "end_char": 1531, "text_sha256": "f466fcced77ee9fe7a97f010112a035332d513382d13e6187d10bc02be152ece"} [citrulline-p19322909] Transport characteristics of L-citrulline in renal apical membrane of proximal tubular cells. (2009). https://pubmed.ncbi.nlm.nih.gov/19322909/ DOI: 10.1002/bdd.653
Complete structured claim and evidenceSilencing SLC7A9 also reduced citrulline uptake in HK-2 cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/19322909.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f466fcced77ee9fe7a97f010112a035332d513382d13e6187d10bc02be152ece", "start_char": 0, "end_char": 1531, "text_sha256": "f466fcced77ee9fe7a97f010112a035332d513382d13e6187d10bc02be152ece"}
- experimental_model
- Apical transport kinetics and transporter knockdown
- exposure
- Citrulline uptake on permeable supports; SLC6A19 or SLC7A9 silencing
- limitations
- Renal evidence must not be relabeled as a demonstrated human intestinal transport mechanism.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human HK-2 cells; rat cultures studied separately
- plain_language
- A separate transporter contributes to the measured uptake.
- primary_references
- [citrulline-p19322909] Transport characteristics of L-citrulline in renal apical membrane of proximal tubular cells. (2009). https://pubmed.ncbi.nlm.nih.gov/19322909/ DOI: 10.1002/bdd.653
- tissue_or_cell_type
- Renal proximal tubular epithelium
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 411–422
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Apical transport kinetics and transporter knockdown · source_derived_draft · unverified_draft
### citrulline-renal-b0plus Silencing SLC7A9 also reduced citrulline uptake in HK-2 cells. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: A separate transporter contributes to the measured uptake. organism: Human HK-2 cells; rat cultures studied separately tissue_or_cell_type: Renal proximal tubular epithelium experimental_model: Apical transport kinetics and transporter knockdown limitations: Renal evidence must not be relabeled as a demonstrated human intestinal transport mechanism. exposure: Citrulline uptake on permeable supports; SLC6A19 or SLC7A9 silencing evidence_span: {"source_cache": "artifacts/citrulline-research/19322909.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f466fcced77ee9fe7a97f010112a035332d513382d13e6187d10bc02be152ece", "start_char": 0, "end_char": 1531, "text_sha256": "f466fcced77ee9fe7a97f010112a035332d513382d13e6187d10bc02be152ece"} [citrulline-p19322909] Transport characteristics of L-citrulline in renal apical membrane of proximal tubular cells. (2009). https://pubmed.ncbi.nlm.nih.gov/19322909/ DOI: 10.1002/bdd.653
Complete structured claim and evidenceHK-2 citrulline uptake included two sodium-dependent saturable components and one sodium-independent component.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/19322909.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f466fcced77ee9fe7a97f010112a035332d513382d13e6187d10bc02be152ece", "start_char": 0, "end_char": 1531, "text_sha256": "f466fcced77ee9fe7a97f010112a035332d513382d13e6187d10bc02be152ece"}
- experimental_model
- Apical transport kinetics and transporter knockdown
- exposure
- Citrulline uptake on permeable supports; SLC6A19 or SLC7A9 silencing
- limitations
- Renal evidence must not be relabeled as a demonstrated human intestinal transport mechanism.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human HK-2 cells; rat cultures studied separately
- plain_language
- Sodium dependence applies to part of the transport system, not every citrulline transporter.
- primary_references
- [citrulline-p19322909] Transport characteristics of L-citrulline in renal apical membrane of proximal tubular cells. (2009). https://pubmed.ncbi.nlm.nih.gov/19322909/ DOI: 10.1002/bdd.653
- tissue_or_cell_type
- Renal proximal tubular epithelium
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 424–435
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Apical transport kinetics and transporter knockdown · source_derived_draft · unverified_draft
### citrulline-renal-sodium HK-2 citrulline uptake included two sodium-dependent saturable components and one sodium-independent component. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Sodium dependence applies to part of the transport system, not every citrulline transporter. organism: Human HK-2 cells; rat cultures studied separately tissue_or_cell_type: Renal proximal tubular epithelium experimental_model: Apical transport kinetics and transporter knockdown limitations: Renal evidence must not be relabeled as a demonstrated human intestinal transport mechanism. exposure: Citrulline uptake on permeable supports; SLC6A19 or SLC7A9 silencing evidence_span: {"source_cache": "artifacts/citrulline-research/19322909.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f466fcced77ee9fe7a97f010112a035332d513382d13e6187d10bc02be152ece", "start_char": 0, "end_char": 1531, "text_sha256": "f466fcced77ee9fe7a97f010112a035332d513382d13e6187d10bc02be152ece"} [citrulline-p19322909] Transport characteristics of L-citrulline in renal apical membrane of proximal tubular cells. (2009). https://pubmed.ncbi.nlm.nih.gov/19322909/ DOI: 10.1002/bdd.653
Complete structured claim and evidenceThe trial reported approximately 40% lower soreness at 24 and 48 hours with CM.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/20386132.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a095891368caeebaa857f5dcf2651e1498924f2006969255d252c1d8caa91847", "start_char": 0, "end_char": 1637, "text_sha256": "a095891368caeebaa857f5dcf2651e1498924f2006969255d252c1d8caa91847"}
- experimental_model
- Randomized double-blind crossover exercise trial
- exposure
- 8 g citrulline malate before a high-volume pectoral session
- limitations
- CM is not pure L-citrulline; last-set relative change is not a whole-workout gain; perceived soreness is subjective.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 41 men
- plain_language
- Participants reported less soreness after this protocol.
- primary_references
- [citrulline-p20386132] Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness. (2010). https://pubmed.ncbi.nlm.nih.gov/20386132/ DOI: 10.1519/jsc.0b013e3181cb28e0
- tissue_or_cell_type
- Bench-press repetitions and self-reported soreness
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1126–1137
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind crossover exercise trial · source_derived_draft · unverified_draft
### citrulline-soreness-decreased The trial reported approximately 40% lower soreness at 24 and 48 hours with CM. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Participants reported less soreness after this protocol. organism: Human, 41 men tissue_or_cell_type: Bench-press repetitions and self-reported soreness experimental_model: Randomized double-blind crossover exercise trial limitations: CM is not pure L-citrulline; last-set relative change is not a whole-workout gain; perceived soreness is subjective. exposure: 8 g citrulline malate before a high-volume pectoral session evidence_span: {"source_cache": "artifacts/citrulline-research/20386132.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a095891368caeebaa857f5dcf2651e1498924f2006969255d252c1d8caa91847", "start_char": 0, "end_char": 1637, "text_sha256": "a095891368caeebaa857f5dcf2651e1498924f2006969255d252c1d8caa91847"} [citrulline-p20386132] Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness. (2010). https://pubmed.ncbi.nlm.nih.gov/20386132/ DOI: 10.1519/jsc.0b013e3181cb28e0
Complete structured claim and evidenceTotal soreness over 72 hours was higher after CM than placebo, P=0.01, without a greater workload.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/30097067.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8f08d4e244a48b116a8a2a734514e0cf13d3953bcae33722f996121bab8efbb2", "start_char": 0, "end_char": 1678, "text_sha256": "8f08d4e244a48b116a8a2a734514e0cf13d3953bcae33722f996121bab8efbb2"}
- experimental_model
- Randomized double-blind counterbalanced exercise study and product analysis
- exposure
- 8 g CM with measured citrulline:malate ratio 1.11:1
- limitations
- Exercise, participant mix and product composition differed from the 2010 study; the cause of discrepant soreness is unproven.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human recreationally active men and women
- plain_language
- This study reported more soreness, the opposite of the earlier soreness result.
- primary_references
- [citrulline-p30097067] Citrulline malate supplementation does not improve German Volume Training performance or reduce muscle soreness in moderately trained males and females. (2018). https://pubmed.ncbi.nlm.nih.gov/30097067/ DOI: 10.1186/s12970-018-0245-8
- tissue_or_cell_type
- Isokinetic German Volume Training and 72-hour soreness
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1165–1176
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind counterbalanced exercise study and product analysis · source_derived_draft · unverified_draft
### citrulline-soreness-increased Total soreness over 72 hours was higher after CM than placebo, P=0.01, without a greater workload. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: This study reported more soreness, the opposite of the earlier soreness result. organism: Human recreationally active men and women tissue_or_cell_type: Isokinetic German Volume Training and 72-hour soreness experimental_model: Randomized double-blind counterbalanced exercise study and product analysis limitations: Exercise, participant mix and product composition differed from the 2010 study; the cause of discrepant soreness is unproven. exposure: 8 g CM with measured citrulline:malate ratio 1.11:1 evidence_span: {"source_cache": "artifacts/citrulline-research/30097067.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8f08d4e244a48b116a8a2a734514e0cf13d3953bcae33722f996121bab8efbb2", "start_char": 0, "end_char": 1678, "text_sha256": "8f08d4e244a48b116a8a2a734514e0cf13d3953bcae33722f996121bab8efbb2"} [citrulline-p30097067] Citrulline malate supplementation does not improve German Volume Training performance or reduce muscle soreness in moderately trained males and females. (2018). https://pubmed.ncbi.nlm.nih.gov/30097067/ DOI: 10.1186/s12970-018-0245-8
Complete structured claim and evidenceStomach discomfort was reported by 14.63% of participants with CM.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/20386132.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a095891368caeebaa857f5dcf2651e1498924f2006969255d252c1d8caa91847", "start_char": 0, "end_char": 1637, "text_sha256": "a095891368caeebaa857f5dcf2651e1498924f2006969255d252c1d8caa91847"}
- experimental_model
- Randomized double-blind crossover exercise trial
- exposure
- 8 g citrulline malate before a high-volume pectoral session
- limitations
- CM is not pure L-citrulline; last-set relative change is not a whole-workout gain; perceived soreness is subjective.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 41 men
- plain_language
- The study preparation was not symptom-free for everyone.
- primary_references
- [citrulline-p20386132] Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness. (2010). https://pubmed.ncbi.nlm.nih.gov/20386132/ DOI: 10.1519/jsc.0b013e3181cb28e0
- tissue_or_cell_type
- Bench-press repetitions and self-reported soreness
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1139–1150
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind crossover exercise trial · source_derived_draft · unverified_draft
### citrulline-stomach-discomfort Stomach discomfort was reported by 14.63% of participants with CM. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The study preparation was not symptom-free for everyone. organism: Human, 41 men tissue_or_cell_type: Bench-press repetitions and self-reported soreness experimental_model: Randomized double-blind crossover exercise trial limitations: CM is not pure L-citrulline; last-set relative change is not a whole-workout gain; perceived soreness is subjective. exposure: 8 g citrulline malate before a high-volume pectoral session evidence_span: {"source_cache": "artifacts/citrulline-research/20386132.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a095891368caeebaa857f5dcf2651e1498924f2006969255d252c1d8caa91847", "start_char": 0, "end_char": 1637, "text_sha256": "a095891368caeebaa857f5dcf2651e1498924f2006969255d252c1d8caa91847"} [citrulline-p20386132] Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness. (2010). https://pubmed.ncbi.nlm.nih.gov/20386132/ DOI: 10.1519/jsc.0b013e3181cb28e0
Complete structured claim and evidenceAscorbate increased intracellular BH4 in porcine aortic endothelial cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/10749876.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed", "start_char": 0, "end_char": 1519, "text_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed"}
- experimental_model
- Cell exposure and recombinant-enzyme assays
- exposure
- Ascorbate loading; BH4 or sepiapterin comparisons
- limitations
- Preclinical experiments; not proof that vitamin C is needed as a co-supplement with citrulline.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Porcine aortic endothelial cells and bovine eNOS
- plain_language
- Vitamin C can affect cofactor availability in this cell model.
- primary_references
- [citrulline-p10749876] Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. (2000). https://pubmed.ncbi.nlm.nih.gov/10749876/ DOI: 10.1074/jbc.m002248200
- tissue_or_cell_type
- BH4 availability and NO bioactivity
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 697–708
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell exposure and recombinant-enzyme assays · source_derived_draft · unverified_draft
### citrulline-vitaminc-bh4 Ascorbate increased intracellular BH4 in porcine aortic endothelial cells. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Vitamin C can affect cofactor availability in this cell model. organism: Porcine aortic endothelial cells and bovine eNOS tissue_or_cell_type: BH4 availability and NO bioactivity experimental_model: Cell exposure and recombinant-enzyme assays limitations: Preclinical experiments; not proof that vitamin C is needed as a co-supplement with citrulline. exposure: Ascorbate loading; BH4 or sepiapterin comparisons evidence_span: {"source_cache": "artifacts/citrulline-research/10749876.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed", "start_char": 0, "end_char": 1519, "text_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed"} [citrulline-p10749876] Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. (2000). https://pubmed.ncbi.nlm.nih.gov/10749876/ DOI: 10.1074/jbc.m002248200
Complete structured claim and evidenceAscorbate had no additional effect at high BH4 or after sepiapterin raised cellular BH4.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/10749876.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed", "start_char": 0, "end_char": 1519, "text_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed"}
- experimental_model
- Cell exposure and recombinant-enzyme assays
- exposure
- Ascorbate loading; BH4 or sepiapterin comparisons
- limitations
- Preclinical experiments; not proof that vitamin C is needed as a co-supplement with citrulline.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Porcine aortic endothelial cells and bovine eNOS
- plain_language
- The benefit depended on the starting cofactor conditions.
- primary_references
- [citrulline-p10749876] Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. (2000). https://pubmed.ncbi.nlm.nih.gov/10749876/ DOI: 10.1074/jbc.m002248200
- tissue_or_cell_type
- BH4 availability and NO bioactivity
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 723–734
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell exposure and recombinant-enzyme assays · source_derived_draft · unverified_draft
### citrulline-vitaminc-bh4-saturation Ascorbate had no additional effect at high BH4 or after sepiapterin raised cellular BH4. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The benefit depended on the starting cofactor conditions. organism: Porcine aortic endothelial cells and bovine eNOS tissue_or_cell_type: BH4 availability and NO bioactivity experimental_model: Cell exposure and recombinant-enzyme assays limitations: Preclinical experiments; not proof that vitamin C is needed as a co-supplement with citrulline. exposure: Ascorbate loading; BH4 or sepiapterin comparisons evidence_span: {"source_cache": "artifacts/citrulline-research/10749876.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed", "start_char": 0, "end_char": 1519, "text_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed"} [citrulline-p10749876] Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. (2000). https://pubmed.ncbi.nlm.nih.gov/10749876/ DOI: 10.1074/jbc.m002248200
Complete structured claim and evidenceAscorbate increased arginine-to-citrulline conversion and NO-related output in porcine endothelial cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/10749876.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed", "start_char": 0, "end_char": 1519, "text_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed"}
- experimental_model
- Cell exposure and recombinant-enzyme assays
- exposure
- Ascorbate loading; BH4 or sepiapterin comparisons
- limitations
- Preclinical experiments; not proof that vitamin C is needed as a co-supplement with citrulline.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Porcine aortic endothelial cells and bovine eNOS
- plain_language
- Protecting the machinery can matter as well as supplying arginine.
- primary_references
- [citrulline-p10749876] Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. (2000). https://pubmed.ncbi.nlm.nih.gov/10749876/ DOI: 10.1074/jbc.m002248200
- tissue_or_cell_type
- BH4 availability and NO bioactivity
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 710–721
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell exposure and recombinant-enzyme assays · source_derived_draft · unverified_draft
### citrulline-vitaminc-no Ascorbate increased arginine-to-citrulline conversion and NO-related output in porcine endothelial cells. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Protecting the machinery can matter as well as supplying arginine. organism: Porcine aortic endothelial cells and bovine eNOS tissue_or_cell_type: BH4 availability and NO bioactivity experimental_model: Cell exposure and recombinant-enzyme assays limitations: Preclinical experiments; not proof that vitamin C is needed as a co-supplement with citrulline. exposure: Ascorbate loading; BH4 or sepiapterin comparisons evidence_span: {"source_cache": "artifacts/citrulline-research/10749876.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed", "start_char": 0, "end_char": 1519, "text_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed"} [citrulline-p10749876] Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. (2000). https://pubmed.ncbi.nlm.nih.gov/10749876/ DOI: 10.1074/jbc.m002248200
Complete structured claim and evidenceReduced ASS1 activity increased cytosolic aspartate availability and CAD-dependent pyrimidine synthesis in the studied cancer models.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human cancer-cell perturbations, metabolic analysis and disease-related comparisons.
- limitations
- The finding does not mean reducing nitrogen disposal is beneficial; it is a tumor-model mechanism.
- nutrient_topic
- L-Aspartate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Aspartate
- plain_language
- Using less aspartate for arginine synthesis can leave more for nucleotide synthesis.
- primary_references
- Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26560030/ · DOI 10.1038/nature15529
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Aspartate: redox transfer, nitrogen partitioning and cross-nutrient mechanisms (2026-09-19) · lines 170–176
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cancer-cell perturbations, metabolic analysis and disease-related comparisons. · source_derived_draft · unverified_draft
## l-aspartate-ass1-diversion Using less aspartate for arginine synthesis can leave more for nucleotide synthesis. Reduced ASS1 activity increased cytosolic aspartate availability and CAD-dependent pyrimidine synthesis in the studied cancer models. Model: Human cancer-cell perturbations, metabolic analysis and disease-related comparisons. Limitations: The finding does not mean reducing nitrogen disposal is beneficial; it is a tumor-model mechanism. Evidence access: Primary abstract Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26560030/ · DOI 10.1038/nature15529
Complete structured claim and evidenceThe second oxygenation yielded NO and citrulline and required added NADPH and calcium/calmodulin.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat cerebellar NOS preparation; separated partial reactions.
- limitations
- Purified preparation; residual enzyme reductant supported a limited first reaction without added NADPH. This does not imply physiological NOS is NADPH independent.
- nutrient_topic
- L-Arginine collection; tissue, species, dose and formulation distinctions retained. · L-Arginine
- plain_language
- The next reaction produces the signal and recycles the carbon skeleton.
- primary_references
- Characteristics of the nitric oxide synthase-catalyzed conversion of arginine to N-hydroxyarginine, the first oxygenation step in the enzymic synthesis of nitric oxide. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7530247/ · DOI 10.1074/jbc.270.4.1721
L-Arginine: transport, metabolic branches, nutrient interactions, availability and discovery questions (2026-09-18) · lines 78–84
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Rat cerebellar NOS preparation; separated partial reactions. · source_derived_draft · unverified_draft
## arg-nos-second The next reaction produces the signal and recycles the carbon skeleton. The second oxygenation yielded NO and citrulline and required added NADPH and calcium/calmodulin. Model: Rat cerebellar NOS preparation; separated partial reactions. Limitations: Purified preparation; residual enzyme reductant supported a limited first reaction without added NADPH. This does not imply physiological NOS is NADPH independent. Evidence access: Primary abstract Characteristics of the nitric oxide synthase-catalyzed conversion of arginine to N-hydroxyarginine, the first oxygenation step in the enzymic synthesis of nitric oxide. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7530247/ · DOI 10.1074/jbc.270.4.1721
Complete structured claim and evidenceAmino-acid loading experiments indicated inhibition of renal citrulline transport by arginine, lysine and ornithine.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Nine men in oral lysine tests; three men in intravenous amino-acid loading tests.
- limitations
- Small historical experiment; no molecular transporter identified and no ordinary-meal effect size established.
- nutrient_topic
- L-Arginine collection; tissue, species, dose and formulation distinctions retained. · L-Arginine
- plain_language
- Related amino acids interacted at a kidney transport step.
- primary_references
- A new transport interaction of dibasic amino acids and citrulline in human kidney. · 1981 · https://pubmed.ncbi.nlm.nih.gov/6797099/ · DOI 10.1620/tjem.134.55
L-Arginine: transport, metabolic branches, nutrient interactions, availability and discovery questions (2026-09-18) · lines 54–60
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Nine men in oral lysine tests; three men in intravenous amino-acid loading tests. · source_derived_draft · unverified_draft
## arg-renal-competition Related amino acids interacted at a kidney transport step. Amino-acid loading experiments indicated inhibition of renal citrulline transport by arginine, lysine and ornithine. Model: Nine men in oral lysine tests; three men in intravenous amino-acid loading tests. Limitations: Small historical experiment; no molecular transporter identified and no ordinary-meal effect size established. Evidence access: Primary abstract A new transport interaction of dibasic amino acids and citrulline in human kidney. · 1981 · https://pubmed.ncbi.nlm.nih.gov/6797099/ · DOI 10.1620/tjem.134.55
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.